DENTSPLY INTERNATIONAL INC. DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. )
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
þ |
|
Definitive Proxy Statement |
o |
|
Definitive Additional Materials |
o |
|
Soliciting Material Pursuant to Section 240.14a-11c or
Section 240.14a-12 |
DENTSPLY INTERNATIONAL INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
|
No fee required. |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined): |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its
filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
|
|
|
|
LOGO
DENTSPLY
International Inc.
World
Headquarters
Susquehanna
Commerce Center
221 W. Philadelphia
Street
York,
PA 17405-0872
(717) 845-7511
Fax
(717) 854-2343
April 13,
2007
Dear
DENTSPLY Stockholder:
You are cordially invited to attend the 2007 Annual Meeting of
Stockholders to be held on Tuesday, May 15, 2007, at
9:30 a.m., at the Companys Employee Meeting Room at
570 West College Avenue, in York, Pennsylvania.
The Annual Meeting will include voting on the matters described
in the accompanying Notice of Annual Meeting and Proxy
Statement, a report on Company operations and discussion.
Whether or not you plan to attend, you can ensure that your
shares are represented at the Annual Meeting by voting your
proxy. You have three ways to vote your proxy. You may vote by
mail by promptly completing, signing, dating and returning the
enclosed proxy card in the envelope provided, you may vote by
telephone by calling
1-800-690-6903
and following the instructions, or you may vote by internet by
following the instructions on the proxy card or going to the
internet at www.proxyvote.com and following the instructions on
that site. Your vote is important. Please take a moment to vote
through one of the above methods.
Sincerely,
Bret W. Wise
Chairman of the Board, President, and
Chief Executive Officer
DENTSPLY
INTERNATIONAL INC.
SUSQUEHANNA COMMERCE CENTER
221 WEST PHILADELPHIA STREET
YORK, PENNSYLVANIA
17405-0872
NOTICE OF
ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON TUESDAY, MAY 15, 2007
The Annual Meeting of Stockholders (the Annual
Meeting) of DENTSPLY International Inc., a Delaware
corporation (the Company), will be held on Tuesday,
May 15, 2007, at 9:30 a.m., local time, at the
Companys Employee Meeting Room, 570 West College
Avenue, York, Pennsylvania, for the following purposes:
1. To elect four Class III directors to serve for a
term of three years and until their respective successors are
duly elected and qualified;
2. To ratify the appointment of PricewaterhouseCoopers LLP,
independent registered public accounting firm, to audit the
books and accounts of the Company for the year ending
December 31, 2007;
3. To approve amendments to the Companys 2002 Equity
Incentive Plan; and
4. To transact such other business as may properly come
before the Annual Meeting and any and all adjournments and
postponements thereof.
The Board of Directors fixed the close of business on
March 27, 2007 as the record date for the determination of
stockholders entitled to notice of and to vote at the Annual
Meeting and any adjournment or postponement thereof.
The enclosed proxy is solicited by the Board of Directors of the
Company. Reference is made to the accompanying Proxy Statement
for further information with respect to the business to be
transacted at the Annual Meeting.
A complete list of the stockholders entitled to vote at the
Annual Meeting will be available during ordinary business hours
for examination by any stockholder, for any purpose germane to
the Annual Meeting, for a period of at least ten days prior to
the Annual Meeting, at the office of the Companys
Secretary, Susquehanna Commerce Center, 221 West
Philadelphia Street, York, Pennsylvania.
The Board of Directors urges you to vote your proxy by mail,
by telephone or through the internet. You are cordially invited
to attend the Annual Meeting in person. The voting of your proxy
will not affect your right to revoke your proxy or to vote in
person if you do attend the Annual Meeting.
By Order of the Board of Directors,
Brian M. Addison
Vice President, Secretary and
General Counsel
York, Pennsylvania
April 13, 2007
YOUR VOTE
IS IMPORTANT, NO MATTER HOW MANY SHARES YOU
OWNED ON THE RECORD DATE.
PLEASE INDICATE YOUR VOTING INSTRUCTIONS ON THE ENCLOSED
PROXY CARD, DATE AND SIGN IT, AND RETURN IT IN THE ENVELOPE
PROVIDED, WHICH IS ADDRESSED FOR YOUR CONVENIENCE AND NEEDS NO
POSTAGE IF MAILED IN THE UNITED STATES. OR, IF YOU WISH,
YOU MAY PROVIDE YOUR PROXY INSTRUCTION USING THE TELEPHONE
BY CALLING
1-800-690-6903,
OR THE INTERNET BY FOLLOWING THE INSTRUCTIONS ON THE
ENCLOSED PROXY CARD. IN ORDER TO AVOID THE ADDITIONAL EXPENSE TO
THE COMPANY OF FURTHER SOLICITATION, WE ASK YOUR COOPERATION IN
VOTING YOUR PROXY PROMPTLY.
DENTSPLY
INTERNATIONAL INC.
SUSQUEHANNA COMMERCE CENTER
221 WEST PHILADELPHIA STREET
YORK, PENNSYLVANIA
17405-0872
Table
of Contents
|
|
|
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
6
|
|
|
|
|
7
|
|
|
|
|
8
|
|
|
|
|
13
|
|
|
|
|
14
|
|
|
|
|
15
|
|
|
|
|
15
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
33
|
|
|
|
|
36
|
|
|
|
|
36
|
|
|
|
|
37
|
|
|
|
|
37
|
|
|
|
|
37
|
|
|
|
|
38
|
|
|
|
|
38
|
|
|
|
|
A-1
|
|
|
|
|
B-1
|
|
|
|
|
C-1
|
|
|
|
|
D-1
|
|
|
|
|
E-1
|
|
DENTSPLY
INTERNATIONAL INC.
SUSQUEHANNA COMMERCE CENTER
221 WEST PHILADELPHIA STREET
YORK, PENNSYLVANIA
17405-0872
PROXY
STATEMENT
GENERAL
INFORMATION
This Proxy Statement is furnished in connection with the
solicitation of proxies by the Board of Directors of DENTSPLY
International Inc., a Delaware corporation (DENTSPLY
or the Company), for use at the Companys 2007
Annual Meeting of Stockholders (together with any and all
adjournments and postponements thereof, the Annual
Meeting) to be held on Tuesday, May 15, 2007, at
9:30 a.m., local time, at the Companys Employee
Meeting Room, 570 West College Avenue, York, Pennsylvania, for
the purposes set forth in the accompanying Notice of Annual
Meeting of Stockholders. This Proxy Statement, together with the
foregoing Notice and the enclosed proxy card, are first being
sent to stockholders on or about April 13, 2007.
The Board of Directors (the Board) fixed the close
of business on March 27, 2007 as the record date for the
determination of stockholders entitled to notice of and to vote
at the Annual Meeting. On the record date, there were
152,006,639 shares of Common Stock of the Company, par
value $.01 per share (Common Stock),
outstanding and entitled to vote. Each share of Common Stock is
entitled to one vote per share on each matter properly brought
before the Annual Meeting. Shares can be voted at the Annual
Meeting only if the stockholder is present in person or is
represented by proxy. The presence, in person or by proxy at the
Annual Meeting, of shares of Common Stock representing at least
a majority of the total number of shares of Common Stock
outstanding on the record date will constitute a quorum for
purposes of the Annual Meeting.
Whether or not you are able to attend the Annual Meeting, you
are urged to vote your proxy, either by mail, telephone or the
internet, which is solicited by the Companys Board of
Directors and which will be voted as you direct. In the absence
of instructions, shares represented by properly provided proxies
will be voted as recommended by the Board of Directors.
Any proxy may be revoked at any time prior to its exercise by
attending the Annual Meeting and voting in person, by notifying
the Secretary of the Company of such revocation in writing or by
delivering a duly executed proxy bearing a later date, provided
that such notice or proxy is actually received by the Company
prior to the taking of any vote at the Annual Meeting.
The cost of solicitation of proxies for use at the Annual
Meeting will be borne by the Company. Solicitations will be made
primarily by mail, facsimile or through the internet, and
employees or agents of the Company may solicit proxies
personally or by telephone.
Brokers, banks and other nominee holders will be requested to
obtain voting instructions of beneficial owners of stock
registered in their names. The Company will reimburse these
record holders for their reasonable
out-of-pocket
expenses incurred in doing so. Shares represented by a duly
completed proxy submitted by a nominee holder on behalf of
beneficial owners will be counted for quorum purposes, and will
be voted to the extent instructed by the nominee holder on the
proxy card or through the internet. The rules applicable to a
nominee holder may preclude it from voting the shares that it
holds on certain kinds of proposals unless it receives voting
instructions from the beneficial owners of the shares (sometimes
referred to as broker non-votes).
ELECTION
OF DIRECTORS
The Restated Certificate of Incorporation and the by-laws of the
Company provide that the number of directors (which is to be not
less than three) is to be determined from time to time by the
Board of Directors. The Board is currently comprised of eleven
persons.
Pursuant to the Companys Restated Certificate of
Incorporation, the members of the Board of Directors are divided
into three classes. Each class is to consist, as nearly as may
be possible, of one-third of the whole number of members of the
Board. The term of the Class III directors expires at the
Annual Meeting. The terms of the Class I and Class II
directors will expire at the 2008 and 2009 Annual Meetings of
Stockholders, respectively. At each Annual Meeting, the
directors elected to succeed those whose terms expire are of the
same class as the directors they succeed and are elected for a
term to expire at the third Annual Meeting of Stockholders after
their election and until their successors are duly elected and
qualified. A director elected to fill a vacancy is elected to
the same class as the director
he/she
succeeds, and a director elected to fill a newly created
directorship holds office until the next election of the class
to which such director is elected.
The four incumbent Class III directors are nominees for
election to the Board this year for a three-year term expiring
at the 2010 Annual Meeting of Stockholders. In the election, the
four persons who receive the highest number of votes actually
cast will be elected. The proxy named in the proxy card and on
the internet voting site intends to vote for the election of the
four Class III nominees listed below unless otherwise
instructed. If a holder does not wish his or her shares to be
voted for a particular nominee, the holder must identify the
exception in the appropriate space provided on the proxy card or
on the internet site, in which event the shares will be voted
for the other listed nominees. If any nominee becomes unable to
serve, the proxy may vote for another person designated by the
Board of Directors or the Board may reduce the number of
directors. The Company has no reason to believe that any nominee
will be unable to serve.
The Companys by-laws require that stockholders seeking to
nominate persons for election to the Board, or to propose other
business to be brought before an Annual Meeting of Stockholders,
comply with certain procedures. See Stockholder Proposals
for Proxy Statement and Nominations in this Proxy
Statement.
Set forth below is certain information with regard to each of
the nominees for election as Class III directors and each
continuing Class I and Class II director.
Nominees
for Election as Class III Directors
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
Paula H. Cholmondeley
Age 59
|
|
Ms. Cholmondeley is a private
consultant on Strategic Planning. She served as the Vice
President and General Manager of Specialty Products for Sappi
Fine Paper, a subsidiary of Sappi Limited from April 2000 until
January 2004, and prior to that from January 1998 until April
2000, she was a private consultant on Strategic Planning and
Mergers and Acquisitions. From 1992 until January 1998,
Ms. Cholmondeley held various management positions with
Owens Corning, including General Manager of Residential
Insulation. Ms. Cholmondeley served as a White House Fellow
and a Special Assistant to the U.S. Trade Representative for
several countries in the Far East from 1982 to 1983. She has
also held a number of significant positions with other companies
including managerial positions with Westinghouse Elevator
Company, and as Chief Financial Officer and Senior Vice
President for Blue Cross of Greater Philadelphia. She is an
independent trustee of Gartmore Capital Mutual Fund. She also
serves on the Boards of Terex Corporation, Ultralife Batteries,
Albany International, and Minerals Technologies, Inc. Ms.
Cholmondeley was appointed to the DENTSPLY Board of Directors in
September 2001.
|
2
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
|
|
|
Michael J. Coleman
Age 63
|
|
Mr. Coleman is the Chairman of
Cool Media Company and a partner in CS&W Associates Media
Management, both based in Cocoa Beach, Florida. He served as
Chairman of Cape Publications in Melbourne, Florida until
retiring from that position on January 1, 2007. He previously
served as Publisher of FLORIDA TODAY and President of the
Gannett Co., Inc., South Newspaper Group from 1991 to April
2006. Mr. Coleman was President and Publisher of the Rockford
(Illinois) Register Star. He serves as a director of Ron Jon
Surf Shops Worldwide, Prime Bank of Melbourne, Florida, and the
Freedom Forum Diversity Institute, based in Nashville,
Tennessee. Mr. Coleman has served as a director of the
Company since the Merger, and prior thereto as a director of
Gendex.
|
|
|
|
John C. Miles II
Age 65
|
|
Mr. Miles served as Chairman of
the Board from May 1998 until May 2005, and remains a
Director of the Company. In January 2004, he retired from his
position as Chief Executive Officer, a position which he held
since January 1, 1996. Mr. Miles served as Vice Chairman of
the Board from January 1, 1997 until becoming Chairman in May
1998. Prior to January 1, 1996, he had been President and Chief
Operating Officer since the Merger, and served as President and
Chief Operating Officer of DENTSPLY International Inc.
(Old Dentsply) prior to its merger with Gendex
Corporation (Gendex) on June 11, 1993 (the
Merger), commencing January 1990. Mr. Miles is
currently serving as a director of Respironics, Inc. Mr. Miles
has been a director of the Company since the Merger and was a
director of Old DENTSPLY commencing January 1990.
|
|
|
|
W. Keith Smith
Age 72
|
|
Mr. Smith served as Senior Vice
Chairman of Mellon Financial Corporation and Mellon Bank, N.A.,
as well as a member of the Board of Directors from 1987 until
1998. In his capacity as head of Mellon Trust, he served as
Chairman and Chief Executive Officer of The Boston Company and
Boston Safe Deposit Company, as well as Chairman of The Dreyfus
Corporation and Buck Consultants Inc. Mr. Smith joined
Mellon in 1987 as Vice Chairman and Chief Financial Officer of
Mellon Bank Corporation and Mellon Bank, N.A., and served in
that capacity until 1990. Mr. Smith is a Chartered Accountant
and a member of the Financial Executives Institute. He serves on
the Boards of Directors of PPL Corporation, LED Medical
Diagnostics, Inc., Baytree National Bank & Trust Co.,
Baytree Bancorp, West Penn Allegheny Health System, Allegheny
General Hospital, River City Brass Band Endowment, Robert Morris
University, and the Greater Pittsburgh Council of the Boy Scouts
of America. Mr. Smith has served as a director of the Company
since the Merger and prior thereto served as a director of Old
DENTSPLY.
|
3
Directors
Continuing as Class I Directors
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
|
|
|
Michael C. Alfano, D.M.D.,
Ph.D.
Age 59
|
|
Dr. Alfano is Executive Vice
President at New York University where he is responsible for
Finance, Budget, Endowment, Real Estate, Facilities, Treasury
and Human Resources. He is also Professor of Basic Science and
Craniofacial Biology at the NYU College of Dentistry since 1998,
where he also served as Dean until 2006. Beginning in 1982 until
1998 he held a number of positions with Block Drug Company,
including Senior Vice President for Research & Technology
and President of Block Professional Dental Products Company. He
served on the Board of Directors of Block Drug Company, Inc.
from 1988 to 1998. He serves as a member of or consultant to
various public health organizations, including the Editorial
Board of the American Journal of Dentistry since 1987, and
served on the Board of Overseers for the School of Dental
Medicine at the University of Pennsylvania from 1992 to 2004. In
addition, Dr. Alfano has served as a consultant to the Consumer
Healthcare Product Association and as the industry
representative to the Non-Prescription Drugs Advisory Committee
of the FDA from 2001 to 2005. He is a founding director of the
Friends of the National Institute for Dental and Craniofacial
Research, and he is a founding director of the not-for-profit
Santa Fe Group. He was also a Trustee of the New York State
Dental Foundation until 2006. Dr. Alfano was appointed to the
DENTSPLY Board of Directors in February, 2001.
|
|
|
|
Eric K. Brandt
Age 44
|
|
Mr. Brandt was appointed Senior
Vice President and Chief Financial Officer of Broadcom
Corporation in March 2007. From September 2005 until March 2007,
he served as President and Chief Executive Officer at Avanir
Pharmaceuticals. Beginning in 1999, he held various positions at
Allergan, Inc., including Corporate Vice President and Chief
Financial Officer until 2001, President of Consumer Eye Care
from 2001 to 2002, and in 2005 until his departure Executive
Vice President of Finance and Technical Operations and Chief
Financial Officer. Prior to joining Allergan, he was Vice
President and Partner at Boston Consulting Group, and a senior
member of the BCG Health Care and Operations practices. He
currently serves on the Board of Vertex Pharmaceuticals, Inc.
and Avanir Pharmaceuticals. Mr. Brandt was appointed to the
DENTSPLY Board of Directors in November 2004.
|
|
|
|
William F. Hecht
Age 64
|
|
Mr. Hecht retired as Chairman and
Chief Executive Officer of PPL Corporation, a diversified
utility and energy services company, on October 1, 2006. He was
elected President and Chief Operating Officer in 1991 and
Chairman in 1993. In addition to PPL Corporation, he served on
the Boards of PPL Electric Utilities Corporation and PPL Energy
Supply, LLC, subsidiaries of PPL Corporation. Mr. Hecht also
serves as a director of the Federal Reserve Bank of Philadelphia
and Renaissance ReHoldings Ltd. He also serves on the Board of a
number of civic and charitable organizations. Mr. Hecht was
appointed to the DENTSPLY Board of Directors in March 2001.
|
4
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
|
|
|
Francis J. Lunger
Age 61
|
|
Mr. Lunger served on the Board of
Millipore Corporation from 2001 until March 2005, including
serving as Chairman from April 2002 until April 2004. Mr. Lunger
joined Millipore in 1997 as Senior Vice President and Chief
Financial Officer and held several executive management
positions, which included serving as Executive Vice President
and Chief Operating Officer from 2000 until 2001, and President
and Chief Executive Officer from August 2001 until January 2005.
Prior to joining Millipore, Mr. Lunger held executive management
positions at Oak Industries, Inc., Nashua Corporation, and
Raychem Corporation. Mr. Lunger was elected to the Dentsply
Board of Directors in May 2005.
|
Directors
Continuing as Class II Directors
|
|
|
Name and Age
|
|
Principal Occupation and Directorships
|
|
Wendy L. Dixon, Ph.D.
Age 51
|
|
Dr. Dixon serves as the President
of Global Marketing and Chief Marketing Officer at Bristol-Myers
Squibb Company, a position she has held since joining the
company in December 2001. She also serves on the Executive
Committee of Bristol-Myers. From 1996 to November 2001, Dr.
Dixon held executive management positions at Merck &
Company, most recently serving as the Senior Vice President of
Marketing. Prior to her employment at Merck, Dr. Dixon held
executive management positions with Osteotech and Centocor and
various positions at SmithKline in marketing, regulatory affairs
and project management. Dr. Dixon was appointed to the DENTSPLY
Board of Directors in July 2005.
|
|
|
|
Leslie A. Jones
Age 67
|
|
Mr. Jones served as Chairman of
the Board of the Company from May 1996 to May 1998. From
January 1991 to January 1992, he was a Senior Vice President and
Special Assistant to the President of Old DENTSPLY. Prior to
that time, Mr. Jones served as Senior Vice President of North
American Operations. Mr. Jones has served as a director of the
Company since the Merger, and prior to the Merger served as a
director of Old DENTSPLY.
|
|
|
|
Bret W. Wise
Age 46
|
|
Mr. Wise joined DENTSPLY in
November 2002 as Senior Vice President and Chief Financial
Officer. In January 2005, he was promoted to Executive Vice
President with responsibility for two of DENTSPLYs four
operating groups, corporate research and development, and
business development activities. In January 2006 Mr. Wise was
promoted to President and Chief Operating Officer, and assumed
his current role as Chairman, CEO and President on
January 1, 2007. Prior to joining DENTSPLY, Mr. Wise was
Senior Vice President and Chief Financial Officer of Ferro
Corporation of Cleveland, Ohio, a global specialty chemical
company, where he also had operating responsibility for
Ferros operations in the Asia Pacific region and global
porcelain enamel business. Prior to that, he was Vice President
and Chief Financial Officer of WCI Steel, Inc. of Warren, Ohio,
and a partner with the accounting and consulting firm of KPMG.
Mr. Wise currently serves on the boards of the Dental Trade
Alliance, the National Foundation of Dentistry for the
Handicapped, and IMS Health. He joined the DENTSPLY board in
August 2006 and was named Chairman in January 2007.
|
5
Votes
Required
The Class III directors will be elected by a plurality of
the votes of shares present and entitled to vote. Accordingly,
the four nominees for election as directors who receive the
highest number of votes actually cast will be elected. Broker
non-votes will be treated as shares that neither are capable of
being voted nor have been voted and, accordingly, will have no
effect on the outcome of the election of directors.
The Board
of Directors unanimously recommends a vote FOR the nominees
for
election as Class III directors.
RATIFICATION
OF APPOINTMENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM
The Audit and Finance Committee appointed PricewaterhouseCoopers
LLP (PwC), independent registered public accounting
firm, to audit the financial statements of the Company and to
audit the Companys internal control over financial
reporting for the year ending December 31, 2007.
In connection with the audit of the Companys financial
statements, it is expected that PwC will also audit the books
and accounts of certain subsidiaries of the Company at the close
of their current fiscal years. A representative of PwC will be
present at the Annual Meeting and will have the opportunity to
make a statement, if such person desires to do so, and to
respond to appropriate questions.
Following is a summary of the fees billed to the Company by
PricewaterhouseCoopers LLP for professional services rendered
during 2006 and 2005, and are categorized in accordance with the
SECs rules on auditor independence as follows:
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
2005
|
|
|
|
($)
|
|
|
($)
|
|
|
Audit (1)
|
|
|
2,591,822
|
|
|
|
2,588,939
|
|
Audit related (2)
|
|
|
75,100
|
|
|
|
51,500
|
|
Tax (3)
|
|
|
78,797
|
|
|
|
100,304
|
|
Total
|
|
|
2,745,719
|
|
|
|
2,740,743
|
|
|
|
|
(1) |
|
The audit fees for the years ended December 31, 2006 and
2005, respectively, were for professional services rendered for
each of the indicated fiscal years in connection with the audits
of the Companys annual consolidated financial statements
included in
Form 10-K
and review of quarterly consolidated financial statements
included in Form
10-Qs, or
for services that are normally provided by the accountants in
connection with statutory and regulatory filings or engagements.
In addition, for the years ended December 31, 2006 and
2005, audit fees included professional services related to the
audit of the Companys internal control over financial
reporting as required by the Sarbanes-Oxley Act of 2002. |
|
(2) |
|
The audit related fees for the years ended December 31,
2006 and 2005, respectively, were for assurance and related
services that are reasonably related to the performance of the
audit or review of the Companys Financial Statements. Such
services include assistance in applying financial accounting and
reporting standards and certain attestation services. |
|
(3) |
|
Tax fees for the years ended December 31, 2006 and 2005,
respectively, were for audit related tax compliance in each of
the indicated fiscal years. |
The Audit and Finance Committee reviewed summaries of the
services provided by PwC and the related fees and determined
that the provision of non-audit services is compatible with
maintaining the independence of PwC.
The Audit and Finance Committee has adopted procedures for
pre-approval of services provided by PwC. Under these
procedures, all services to be provided by PwC must be
pre-approved by the Audit and Finance Committee, or can be
pre-approved by the Chairman of the Audit and Finance Committee
subject to ratification by the Committee at its next meeting.
Management makes a presentation to the Committee (or the
Chairman of the Committee, as applicable) describing the types
of services to be performed and the projected budget for such
services. Following this presentation, the Committee advises
Management of the services that are approved and the
6
projected level of expenditure for such services. All of the
fees reported above were approved by the Audit Committee in
accordance with their procedures.
The proposal to ratify the appointment of PwC will be approved
by the stockholders if it receives the affirmative vote of a
majority of the shares present in person or represented by proxy
at the meeting and entitled to vote on the proposal. If there is
an abstention noted on the proxy card for this proposal, the
abstention will have the effect of a vote against the proposal
even though the shares represented thereby will not be counted
as having been voted for or against the proposal. Broker
non-votes will be treated as shares not capable of being voted
on the proposal and, accordingly, will have no effect on the
outcome of voting on the proposal.
The Audit
and Finance Committee and the Board of Directors recommend a
vote FOR ratification of the selection of PwC as
independent registered public accounting firm for the
Company.
APPROVE
AMENDMENTS TO THE COMPANYS 2002 EQUITY INCENTIVE
PLAN
AMENDMENT
TO THE 2002 AMENDED AND RESTATED EQUITY INCENTIVE PLAN TO
ELIMINATE AUTOMATIC STOCK OPTION GRANTS TO OUTSIDE DIRECTORS AND
TO INCLUDE PERFORMANCE CRITERIA WITH RESPECT TO THE GRANT OF
PERFORMANCE-BASED
RESTRICTED STOCK AND RESTRICTED STOCK UNITS
We are asking stockholders to approve an amendment to our 2002
Amended and Restated Equity Incentive Plan (the
Plan) to eliminate automatic stock option grants to
members of the Companys Board of Directors who are not
employees of the Company (Outside Directors) and to
incorporate specific performance-based criteria with respect to
the grant of restricted stock and restricted stock units.
Elimination
of Automatic Grant Program
The Plan currently provides that Outside Directors automatically
receive a nonqualified stock option grant upon first joining the
Board, and an additional option grant every three years
thereafter that they continue to serve as an Outside Director
(or an equivalent grant of restricted stock, restricted stock
units, or stock appreciation rights). The Companys Board
of Directors recently retained an independent compensation
consultant, Towers Perrin, to provide it with information and
recommendations concerning current market and peer-company
practices in compensating non-employee directors, including
stock-based compensation. Based on such information and
recommendations, the Companys Board of Directors has
determined that it would be in the best interest of the Company
and its stockholders to eliminate these automatic grants and to
provide instead that grants under the Plan to Outside Directors,
like grants to Key Employees, consultants and advisors, would be
made in the discretion of the Human Resources Committee of the
Board of Directors.
The full text of the amendments to the Plan are set forth in
Appendix A to this Proxy.
Inclusion
of Performance Criteria
Section 162(m) of the Code
(Section 162(m)) disallows a Federal income tax
deduction to a publicly held company for compensation that is
paid to its chief executive officer, chief financial officer and
its three other most highly compensated executive officers
(covered employees) to the extent such compensation
exceeds $1,000,000 annually. The limitation does not apply to
compensation that qualifies as performance-based
under regulations promulgated under Section 162(m). Among
other requirements, performance-based compensation is
compensation that is paid solely on account of one or more
pre-established, objective performance goals, the material terms
of which have been disclosed to and approved by the stockholders
of the publicly held company.
The Board has determined that the Company should preserve its
ability to deduct the amount of compensation paid to its covered
employees to the extent practicable. Accordingly, the Board is
recommending that stockholders approve the material terms of
performance goals that the Human Resources Committee may apply
to grants of restricted stock and restricted stock units so that
such awards qualify as performance-based for
purposes of Section 162(m). If stockholders approve the
amendment, the Human Resources Committee may grant restricted
7
stock and restricted stock unit awards subject to the attainment
of performance goals in addition to, or in lieu of, time-based
vesting conditions.
The performance goals are described in detail in
Paragraph 9 of the amendments to the Plan in
Appendix A. Under the plan no more than two million
(2,000,000) shares may be awarded as restricted stock or
restricted stock units, and in any calendar year no key employee
may be granted restricted stock and restricted stock units in
excess of 150,000 shares of common stock.
If stockholders approve the amendment, subject to compliance
with other factors that must be met to satisfy the
performance-based compensation requirements, the Company will be
able to fully deduct compensation that is paid to its covered
employees in the form of restricted stock and restricted stock
units upon the attainment of specified performance measures. The
Company can currently fully deduct compensation that is paid to
its covered employees in the form of stock options and stock
appreciation rights since the plan was structured to comply with
the performance-based requirements applicable to such awards.
DESCRIPTION
OF THE 2002 AMENDED AND RESTATED EQUITY INCENTIVE
PLAN
The following is a summary of the principal features of the Plan
with the proposed Amendments.
General
Provisions
Types of Award. Stock options
(Options), stock which is subject to certain
forfeiture risks and restrictions (Restricted
Stock), stock delivered upon vesting of units
(Restricted Stock Units) and stock appreciation
rights (Stock Appreciation Rights) may be awarded
under the Equity Incentive Plan (collectively,
Awards).
Administration. The Equity Incentive Plan is
administered by the Human Resources Committee, or a Subcommittee
thereof (the Committee), of the Board. The Committee
is comprised of two or more members of the Board, each of whom
qualifies as a Non-Employee Director as defined in
Rule 16b-3
under the Securities Exchange Act of 1934, as amended (the
1934 Act), or any successor rule or regulation,
independent directors as defined in
Section 4200(15) of the Marketplace Rules of The Nasdaq
Stock Market and outside directors as defined in
Section 162(m) or any successor provision of the Code and
applicable Treasury regulations thereunder, if such
qualification is deemed necessary in order for the grant or the
exercise of Options under the Equity Incentive Plan to qualify
for any tax or other material benefit to participants or the
Company under applicable law. Subject to the express provisions
of the Equity Incentive Plan, the Committee will have sole
discretion concerning all matters relating to the Equity
Incentive Plan and Awards, including, without limitation, those
persons to whom Awards will be granted, the number of shares
subject to each Award and the vesting schedule and expiration
date of such Award.
Eligibility. The Committee will select those
officers and other key employees of the Company, including
members of the Board who are also employees (Employee
Directors), members of the Board who are not employees of
the Company (Outside Directors), and consultants and
advisors to the Company to participate in the Equity Incentive
Plan on the basis of the importance of their services in the
management, development and operations of the Company. Officers,
other key employees and Employee Directors are collectively
referred to as Key Employees.
Shares Available. Awards with respect to
an aggregate of seven million (7,000,000) shares of Common Stock
(plus any shares of Common Stock covered by any unexercised
portion of canceled or terminated stock options granted under
the DENTSPLY International Inc. 1993 Stock Option Plan or 1998
Stock Option Plan), may be granted under the Equity Incentive
Plan (the Maximum Number). Since Awards have already
been made under the 2002 Plan, subject to the adjustment
described below, the current number of shares available for
issuance under the Equity Incentive Plan is 5,157,752. The
Maximum Number will be increased on January 1 of each calendar
year during the term of the Equity Incentive Plan to equal seven
percent (7%) of the outstanding shares of Common Stock on such
date, in the event that 7,000,000 shares is less than seven
percent (7%) of the outstanding shares of Common Stock on such
date, prior to such increase, provided that notwithstanding any
such adjustment in the Maximum Number, all Awards granted under
the Plan, subject to forfeitures or cancellations, shall be
counted against the Maximum Number. Notwithstanding the
foregoing, and subject to adjustment as provided below,
(i) Options with respect to no more than one million
(1,000,000) shares of Common Stock may be granted as ISOs under
the Plan,
8
(ii) no more than two million (2,000,000) shares may be
awarded as Restricted Stock or Restricted Stock Units under the
Plan, and (iii) in any calendar year no Key Employee may be
granted Awards with respect to more than five hundred thousand
(500,000) shares of Common Stock or Restricted Stock and
Restricted Stock Units in excess of 150,000 shares of
Common Stock. Any shares of Common Stock reserved for issuance
upon exercise of Options or Stock Appreciation Rights which
expire, terminate or are cancelled, and any shares of Common
Stock subject to any grant of Restricted Stock or Restricted
Stock Units which are forfeited, may again be subject to new
Awards under the Plan.
Adjustments. The number of shares of Common
Stock subject to the Equity Incentive Plan, the exercise price
of Awards and the number of shares available for Awards
subsequently granted under the Equity Incentive Plan will be
appropriately adjusted to reflect any stock dividend, stock
split or combination of shares. In the event of any merger,
consolidation or reorganization of the Company, there will be
substituted on an equitable basis for each share of Common Stock
then subject to the Equity Incentive Plan and for each share of
Common Stock then subject to an Award granted under the Equity
Incentive Plan, the number and kind of shares of stock, other
securities, cash or other property to which the holders of
Common Stock of the Company are entitled pursuant to such
transaction.
Options
Subject to the terms of the Equity Incentive Plan, the Committee
may from time to time grant Options which are incentive stock
options (ISOs) meeting the requirements of
Section 422 of the Code to Key Employees, or options which
do not meet such requirements (Nonqualified Options
or NSOs), to Key Employees or Outside Directors of,
or consultants or advisors to, the Company; provided, however:
(a) the exercise price per share of each ISO will be the
fair market value of a share of Common Stock on the date such
ISO is granted. For purposes of the Plan, Fair Market
Value shall mean the closing sales price of the Common
Stock on The Nasdaq National Market, or other national
securities exchange which is the principal securities market on
which the Common Stock is traded (as reported in The Wall Street
Journal, Eastern Edition); (b) the aggregate fair market
value (determined with respect to each ISO at the time such
Option is granted) of the shares of Common Stock with respect to
which ISOs are exercisable for the first time by an Optionee
during any calendar year (under all incentive stock option plans
of the Company) will not exceed $100,000; and (c) if an ISO
is granted to an individual who owns stock possessing more than
ten percent (10%) of the total combined voting power of all
classes of stock of the Company, (i) the exercise price of
each ISO will not be less than one hundred ten percent (110%) of
the fair market value of a share of Common Stock on the date the
ISO is granted, and (ii) the ISO will expire and all rights
to purchase shares thereunder will cease no later than the fifth
anniversary of the date the ISO was granted. NSOs will be in
such form and subject to such restrictions and other terms and
conditions as the Committee may determine, provided, however,
that the exercise price per share of each NSO will not be less
than the fair market value of a share of Common Stock on the
date the NSO is granted. Each Option will vest in three equal
annual installments commencing on the first anniversary of the
date of grant, provided, however, that the Committee, in its
sole discretion, will have the authority to shorten or lengthen
the exercise period with respect to any or all Options, or any
part thereof, granted under the Plan.
Stock
Appreciation Rights
The Committee may award Stock Appreciation Rights in tandem with
another Award, in addition to another Award, or freestanding and
unrelated to another Award. The Committee will determine the
number of shares of Common Stock to be issued pursuant to a
Stock Appreciation Right Award, the grant price and the
conditions and limitations applicable to the exercise. A Stock
Appreciation Right entitles the recipient to receive, upon
exercise, an amount equal to the product of (a) the excess
of the fair market value of a share of Common Stock on the date
of exercise over the grant price and (b) the number of
shares of Common Stock as to which the Stock Appreciation Right
is being exercised. Payment will be made by the Company solely
in shares of Common Stock, provided that, the Stock Appreciation
Rights which are settled shall be counted in full against the
number of shares available for award under the Plan, regardless
of the number of shares of Common Stock issued upon settlement
of the Stock Appreciation Right. Stock Appreciation Rights will
vest with respect to one-third of the total number of shares of
Common Stock subject to the Stock Appreciation Right on the
first anniversary following the date of grant, and with respect
to an additional one-third of the total number of shares of
Common Stock subject to the Stock Appreciation
9
Right, on each of the second and third anniversaries. The
Committee, in its sole discretion, may shorten or lengthen the
vesting schedule. Notwithstanding the foregoing, a tandem stock
appreciation right will be exercisable at such time or times and
only to the extent that the related Award is exercisable.
Restricted
Stock and Restricted Stock Units
The Committee may award shares of Restricted Stock
and/or
Restricted Stock Units on such terms as it deems advisable,
including performance requirements established by the Committee.
Restrictions on shares of Restricted Stock
and/or
Restricted Stock Units will lapse over a period of time or
according to such other criteria (including performance-based
criteria) as the Committee deems appropriate (the
Restricted Period). During the Restricted Period,
the recipient may not sell or otherwise dispose of the shares of
Restricted Stock or Restricted Stock Units. During the
Restricted Period, the recipient will have the right to vote
shares of Restricted Stock and to receive any dividends or other
distributions paid on such shares of Restricted Stock, subject
to any restrictions deemed appropriate by the Committee. All
restrictions imposed on Restricted Stock
and/or
Restricted Stock Units will lapse upon the expiration of the
applicable Restricted Period and the satisfaction of all
conditions imposed by the Committee. Upon the lapse of
restrictions with respect to any Restricted Stock Units, the
value of such Restricted Stock Units will be paid to the
recipient in shares of Common Stock (determined as of the date
on which restrictions with respect to such Restricted Stock
Units lapse).
Effect of
Termination of Employment or Service
Except in the event of death, disability, retirement or a
Change in Control or as otherwise determined by the
Committee, the right to exercise any Option or Stock
Appreciation Right held by a participant whose employment with
the Company or service on the Board is terminated for any reason
other than Cause (as defined in the Equity Incentive
Plan) will terminate 90 days following the date of
termination of employment or service on the Board. The right to
exercise any Option or Stock Appreciation Right held by a
recipient whose employment with the Company or service on the
Board is terminated for Cause will terminate on the
date of termination of employment. Unless otherwise provided in
the Equity Incentive Plan or determined by the Committee,
vesting of Options and Stock Appreciation Rights ceases upon
termination of a recipients employment or relationship
with the Company.
If a recipient who has received Restricted Stock
and/or
Restricted Stock Units ceases to be employed by or to provide
service to the Company during the Restricted Period, or if other
specified conditions are not met, the Restricted Stock
and/or
Restricted Stock Units will terminate as to all shares covered
by the Award as to which the restrictions have not lapsed, and,
in the case of Restricted Stock, those shares of Common Stock
shall be canceled in exchange for the purchase price, if any,
paid by the recipient for such shares. The Committee may
provide, however, for complete or partial exceptions to this
requirement as it deems appropriate.
In the event of the death or Disability (as defined in the
Equity Incentive Plan) of a recipient during employment with the
Company or service on the Board, all Options and Stock
Appreciation Rights held by the recipient will become fully
exercisable on such date of death or Disability, all
restrictions and conditions on all Restricted Stock
and/or
Restricted Stock Units held by the recipient will lapse on such
date of death or Disability and the recipient (estate in the
case of death) will have one (1) year from the date of
death or disability to exercise any NSOs and Stock Appreciation
Rights.
If a recipient who is not a director of the Company retires at
or after age 65 or at or after age 60 with a minimum
of 15 years of service with the Company, (a) the
Options and Stock Appreciation Rights held by such recipient
will become fully exercisable as of the date of such retirement
and expire on the earlier of the fifth anniversary of the date
of such retirement or the date that they expire in accordance
with their terms and (b) all restrictions and conditions on
all Restricted Stock
and/or
Restricted Stock Units held by such Key Employee shall lapse on
the date of such retirement. If the service of an Outside
Director is terminated in accordance with the Companys
retirement policy for directors, (a) all Options held by
such director shall become fully exercisable on the date of such
retirement and expire on the earlier of the fifth anniversary of
the date of such retirement or the date that they expire in
accordance with their terms and (b) all restrictions and
conditions on all Restricted Stock
and/or
Restricted Stock Units held by such Outside Director shall lapse
on the date of such retirement. If a Key Employee who is an
Employee Director terminates employment with the Company at or
after age 65 or at or after age 60 with a minimum of
15 years of
10
service with the Company and continues to serve as a director,
then upon the retirement of such director from the board
(a) all Options held by such director shall become fully
exercisable on the date of such retirement and each of the
Options held by such director shall expire on the earlier of the
fifth anniversary of the date of such retirement or the date
that they expire in accordance with their terms and (b) all
restrictions and conditions on all Restricted Stock
and/or
Restricted Stock Units held by such director shall lapse on the
date of such retirement.
Exercise
of Options
Except as otherwise provided in the Equity Incentive Plan or in
any Option agreement or grant certificate, the Optionee will pay
the full exercise price of each Option upon the date of exercise
of such Option (a) in cash, (b) pursuant to a cashless
exercise arrangement with a broker on such terms as the
Committee may determine, (c) by delivering shares of Common
Stock held by the Optionee for at least six (6) months and
having an aggregate fair market value on the date of exercise
equal to the Option exercise price, (d) in the case of a
Key Employee, by such other medium of payment as the Committee,
in its sole discretion, will authorize, or (e) by any
combination of (a), (b), (c), and (d).
Withholding
Obligations
The Company has the right to withhold from any Award, from any
payment due or transfer made under any Award or under the Equity
Incentive Plan or from any compensation or other amount owing to
a participant the amount (in cash, shares or other property) of
any applicable withholding or other taxes in respect of an
Award, its exercise, or any payment or transfer under an Award
or under the Equity Incentive Plan and to take such other action
as may be necessary in the opinion of the Committee to satisfy
all obligations for the payment of such taxes.
Change in
Control
Immediately upon a Change in Control (as defined in
the Equity Incentive Plan), all outstanding Options and Stock
Appreciation Rights, whether or not otherwise exercisable as of
the date of such Change in Control, will become fully
exercisable and all restrictions thereon will terminate in order
that optionees may fully realize the benefits thereunder, and
all restrictions and conditions on all Restricted Stock and
Restricted Stock Units granted to Key Employees or Outside
Directors shall lapse upon the effective date of the Change of
Control. The Committee may determine in its discretion (but
shall not be obligated to do so) that any or all holders of
outstanding Options and Stock Appreciation Right Awards which
are exercisable immediately prior to a Change of Control
(including those that become exercisable upon the Change in
Control) will be required to surrender them in exchange for a
payment, in cash or Common Stock as determined by the Committee,
equal to the value of such Options and Stock Appreciation Rights
(as determined by the Committee in its discretion), with such
payment to take place as of the date of the Change in Control or
such other date as the Committee may prescribe. The acceleration
described above also applies if following a reorganization,
merger or combination in which new shareholders comprise at
least forty-five percent (45%) of the ownership of the Common
Stock or voting power in the Company, a Key Employee
grantees employment is terminated other than for Cause (as
defined in the Plan) or if a Key Employee grantee voluntarily
terminates his or her employment in certain circumstances.
Termination,
Amendment and Term of the Equity Incentive Plan
The Board or the Committee may terminate, suspend, or amend the
Equity Incentive Plan, in whole or in part, from time to time,
without the approval of the stockholders of the Company
provided, however, that no amendment will be effective until
approved by the stockholders of the Company if such stockholder
approval is required in order for the Equity Incentive Plan to
continue to satisfy the requirements of applicable tax or other
laws. No amendment or termination of the Equity Incentive Plan
will adversely affect any Option theretofore granted without the
consent of the Optionee. Unless earlier terminated in accordance
herewith, the Equity Incentive Plan will terminate on
March 22, 2012. Termination of the Equity Incentive Plan
will not affect Awards previously granted thereunder.
11
New
Equity Incentive Plan Benefits
As described above, the Key Employees of the Company and Outside
Directors who receive Awards under the Equity Incentive Plan are
to be determined by the Committee in its discretion.
Accordingly, it is not possible to predict the amounts that will
be received by or allocated to particular Outside Directors, Key
Employees or groups of Key Employees under the Equity Incentive
Plan.
Certain
Federal Income Tax Consequences
The following is a brief summary of the federal income tax
consequences of awards under the Plan based upon current federal
income tax laws. The summary is not intended to be comprehensive
and, among other things, does not describe state, local or
foreign tax consequences.
The award of an ISO will have no immediate tax consequences to
the Company or the optionee. However, in the year of exercise,
the difference between the fair market value of the shares at
the time of exercise and the exercise price of the Option is an
item of tax preference subject to the possible application of
the alternative minimum tax. If an optionee does not dispose of
shares received upon exercise of an ISO for at least two years
after the date of the ISO award and for at least one year from
the date of exercise (a disqualifying disposition),
gain or loss on a subsequent sale or exchange of the shares will
be a capital gain or loss in the amount of the difference
between the amount realized on the sale or exchange and the
exercise price (or the recipients other tax basis in the
shares) at a tax rate which will depend on the length of time
the shares were held and other factors. If there is a
disqualifying disposition, the optionee generally will recognize
compensation income equal to the lesser of (i) the excess
of the fair market value of the shares on the exercise date over
the exercise price, or (ii) the excess of the amount
realized on disposition over the exercise price. Any additional
gain will be taxable as a capital gain, and any loss will be
treated as a capital loss. Upon any such disqualifying
disposition by an optionee, the Company will be entitled to a
deduction in the amount of compensation income realized by the
optionee.
The award of an NSO will have no immediate tax consequences to
the Company or the optionee. Upon exercise of a NSO, an optionee
will recognize ordinary income in an amount equal to the
difference between the exercise price of the NSO and the fair
market value of the shares on the date of exercise. The Company
will be entitled to a corresponding tax deduction at the time of
exercise.
The award of a stock appreciation right will have no immediate
tax consequences to the Company or the recipient. Upon exercise
of the Stock Appreciation Right, the recipient will recognize
ordinary income in an amount equal to the difference between the
grant price of the Stock Appreciation Right and the fair market
value of the shares received.
The grant of Restricted Stock normally will not result in the
recognition of taxable income if the stock is not transferable
and is subject to a substantial risk of forfeiture for federal
tax purposes. When the stock is either transferable or is no
longer subject to a substantial risk of forfeiture, the
recipient will have taxable income in an amount equal to the
fair market value of the shares (less any amount paid for the
shares) at that time and the Company will have a corresponding
deduction. Alternatively, the recipient of Restricted Stock may
elect to recognize taxable income when Restricted Stock is
granted. This election is referred to as a
section 83(b) election. The amount of the
taxable income will be an amount equal to the fair market value
of the shares (less any amount paid for the shares) on the date
of grant. Any gain or loss recognized by the recipient upon a
later sale of the shares will be capital gain or loss. If a
recipient chooses to make a section 83(b) election at the
time of an award of Restricted Stock and then forfeits the
shares (for example, by terminating employment during the
Restriction Period), the recipient will not be entitled to any
tax deduction or tax refund with respect to the tax previously
paid.
The grant of a Restricted Stock Unit will not result in the
recognition of taxable income. Taxation is deferred until shares
are actually delivered upon vesting of the Restricted Stock
Unit. The Company is entitled to a tax deduction upon inclusion
in the recipients income of the value of the shares
delivered. Restricted Stock Units do not qualify for the 83(b)
election, because the Restricted Stock Unit does not represent
actual property, like a share of stock, but is simply a promise
by the Company to issue fully-vested shares in the future if the
recipient completes the requisite service period.
12
YOU ARE NOT
BEING ASKED TO APPROVE ANY ADDITIONAL SHARES FOR ISSUANCE
UNDER THE PLAN.
THE BOARD
OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR THE
PROPOSAL TO
APPROVE THE AMENDMENTS TO THE 2002 EQUITY INCENTIVE
PLAN.
PRINCIPAL
BENEFICIAL OWNERS OF SHARES
The following table sets forth certain information with respect
to all persons or groups known by the Company to be the
beneficial owners of more than 5% of its outstanding Common
Stock as of March 27, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Owned
|
|
|
|
|
|
|
|
|
|
Beneficially
|
|
|
|
|
|
|
|
Five Percent Stockholders
|
|
Number
|
|
|
Percent
|
|
|
|
|
|
|
|
|
FMR Corp
|
|
|
9,711,764
|
(1)
|
|
|
6.4
|
|
|
|
|
|
|
|
|
|
82 Devonshire Street
Boston, MA 02109
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The DENTSPLY International
Inc.
|
|
|
8,548,702
|
(2)
|
|
|
5.6
|
|
|
|
|
|
|
|
|
|
Employee Stock Ownership Plan
Trust
c/o T. Rowe Price
P. O. Box 17349
Baltimore, MD
21297-1349
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Based on information contained in the Amended Schedule 13G
filed by FMR Corp. on February 14, 2007. |
|
(2) |
|
Participants in the Company ESOP have the right to direct the
trustee of the Company ESOP as to the voting of shares allocated
to such participants accounts on all matters submitted to
a vote of the stockholders of the Company, including the
election of directors. Unallocated shares and shares as to which
no directions are received by the trustee of the Company ESOP
are voted as directed by the Company ESOP Committee, which
consists of certain employees of the Company. As of
March 27, 2007, 8,548,702 of the shares held by the trust
holding the assets of the Company ESOP were allocated to
participant accounts and no shares remained unallocated. Each
Company ESOP participant who is fully vested is entitled to
receive a distribution of all of the shares of common stock
allocated to his or her account as soon as practicable after
such participants employment with the Company terminates.
In general, except for certain participants who are age 55
or older and have been participants in the Company ESOP for at
least 10 years, or who have vested balances that exceed six
times their previous years salary, participants are not
entitled to sell shares allocated to their accounts until their
employment has terminated and the shares allocated to such
participants accounts are distributed to them. |
13
STOCK
OWNERSHIP BY DIRECTORS AND EXECUTIVE OFFICERS
The following table sets forth information regarding the
beneficial ownership of the Companys Common Stock as of
March 27, 2007 held by (i) the Companys chief
executive officer, chief financial officer and the other named
executive officers, (ii), each director and nominee for director
and (iii) all directors and executive officers of the
Company as a group (based on 152,006,639 shares of Common
Stock outstanding as of such date).
|
|
|
|
|
|
|
|
|
|
|
Shares Owned
|
|
|
|
Beneficially
|
|
Stock Ownership by Executive Officers and Directors
|
|
Number
|
|
|
Percent
|
|
|
Gerald K. Kunkle, Jr.
|
|
|
777,818
|
(1)
|
|
|
*
|
|
William R. Jellison
|
|
|
471,296
|
(2)
|
|
|
*
|
|
Bret W. Wise
|
|
|
287,179
|
(3)
|
|
|
*
|
|
Christopher T. Clark
|
|
|
277,370
|
(4)
|
|
|
*
|
|
Brian M. Addison
|
|
|
281,998
|
(5)
|
|
|
*
|
|
Dr. Michael C. Alfano
|
|
|
23,824
|
(6)
|
|
|
*
|
|
Eric K. Brandt
|
|
|
12,392
|
(7)
|
|
|
*
|
|
Paula H. Cholmondeley
|
|
|
37,043
|
(8)
|
|
|
*
|
|
Michael J. Coleman
|
|
|
78,509
|
(9)
|
|
|
*
|
|
Wendy L. Dixon
|
|
|
6,667
|
(10)
|
|
|
*
|
|
William F. Hecht
|
|
|
48,190
|
(11)
|
|
|
*
|
|
Leslie A. Jones
|
|
|
246,388
|
(12)
|
|
|
*
|
|
Francis J. Lunger
|
|
|
8,039
|
(13)
|
|
|
*
|
|
John C. Miles II
|
|
|
17,667
|
(14)
|
|
|
*
|
|
W. Keith Smith
|
|
|
141,403
|
(15)
|
|
|
*
|
|
All directors and executive
officers as a group (19 persons)
|
|
|
3,370,906
|
(16)
|
|
|
2.2
|
|
|
|
|
* |
|
Less than 1% |
|
(1) |
|
Includes 13,008 shares allocated to the Company ESOP
account of Mr. Kunkle, 15,000 shares held in
Mr. Kunkles individual retirement account,
132,200 shares which were exercised on March 29 and
March 30, 2007, 266,234 shares which could be acquired
pursuant to the exercise of options exercisable during 2008,
316,744 shares which could be acquired pursuant to the
exercise of options exercisable during 2009 and
4,632 shares which could be acquired pursuant to the SERP
upon retirement or termination from the Company. |
|
(2) |
|
Includes 3,000 shares held by a Mr. Jellisons
family trust, 9,981 shares allocated to the Company ESOP
account of Mr. Jellison, 430,203 shares which could be
acquired pursuant to the exercise of options exercisable within
60 days of March 27, 2007 and 16,687 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(3) |
|
Includes 500 shares held by Mr. Wises spouse,
2,391 shares allocated to the Company ESOP account of
Mr. Wise, 269,530 shares which could be acquired
pursuant to the exercise of options exercisable within
60 days of March 27, 2007 and 9,758 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(4) |
|
Includes 27,740 shares allocated to the Company ESOP
account of Mr. Clark, 240,238 shares which could be
acquired pursuant to the exercise of options exercisable within
60 days of March 27, 2007 and 9,392 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(5) |
|
Includes 16,648 shares allocated to the Company ESOP
account of Mr. Addison, 251,992 shares which could be
acquired pursuant to the exercise of options exercisable within
60 days of March 27, 2007 and 10,358 shares which
could be acquired pursuant to the SERP upon retirement or
termination from the Company. |
|
(6) |
|
Consists of 18,000 shares, which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 27, 2007. |
14
|
|
|
(7) |
|
Consists of 12,000 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 27, 2007 and 392 shares which could be acquired
pursuant to the Deferred Plan when Mr. Brandt ceases to be
a Board member. |
|
(8) |
|
Consists of 30,000 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 27, 2007 and 7,043 shares which could be
acquired pursuant to the Deferred Plan when
Ms. Cholmondeley ceases to be a Board member. |
|
(9) |
|
Includes 12,600 shares held by Mr. Colemans
spouse, 42,000 shares which could be acquired pursuant to
exercise of options exercisable within 60 days of
March 27, 2007 and 17,909 shares which could be
acquired pursuant to the Deferred Plan when Mr. Coleman
ceases to be a Board member. |
|
(10) |
|
Consists of 6,667 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 27, 2007. |
|
(11) |
|
Consists of 36,000 shares which could be acquired pursuant
to the exercise of options exercisable within 60 days of
March 27, 2007 and 12,190 shares which could be
acquired pursuant to the Deferred Plan when Mr. Hecht
ceases to be a Board member. |
|
(12) |
|
Includes 46,000 shares held by Mr. Jones spouse,
42,000 shares which could be acquired pursuant to exercise
of stock options exercisable within 60 days of
March 27, 2007 and 14,330 shares which could be
acquired pursuant to the Deferred Plan when Mr. Jones
ceases to be a Board member. |
|
(13) |
|
Includes 6,000 shares which could be acquired pursuant to
exercise of stock options exercisable within 60 days of
March 27, 2007 and 2,039 shares that could be acquired
pursuant to the Deferred Plan when Mr. Lunger ceases to be
a Board member. |
|
(14) |
|
Includes 6,667 shares which could be acquired pursuant to
exercise of stock options exercisable within 60 days of
March 27, 2007. |
|
(15) |
|
Includes 42,000 shares which could be acquired pursuant to
exercise of stock options exercisable within 60 days of
March 27, 2007 and 25,693 shares which could be
acquired pursuant to the Deferred Plan when Mr. Smith
ceases to be a Board member. |
|
(16) |
|
Includes 62,660 shares held by or for the benefit of
others, 15,000 shares held in individual retirement
accounts, 570 shares held in 401(k) accounts,
135,226 shares allocated to employees ESOP accounts,
2,692,434 shares which could be acquired pursuant to the
exercise of options exercisable within 60 days of
March 27, 2007, 79,596 shares which could be acquired
pursuant to the Deferred Plan when directors cease to be Board
members and 69603 shares which could be acquired pursuant
to the SERP upon retirement or termination of executive officers
from the Company. |
SECTION 16(a)
BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Under federal securities laws, the Companys directors,
certain officers, and persons holding more than 10% of the
Common Stock of the Company are required to report, within
specified due dates, their initial ownership and any subsequent
changes in ownership of the Companys securities to the
Securities and Exchange Commission. The required reporting
periods were significantly reduced in August 2002 for most
reports to two business days. The Company is required to
describe in this proxy statement whether it has knowledge that
any person required to file such report may have failed to do so
in a timely manner. Based upon reports furnished to the Company
and written representations and information provided to the
Company by the persons, the Company believes that during fiscal
2006, all such persons complied with all applicable filing
requirements, except that, one report was filed one day late in
connection with the allocation of phantom stock to the
Directors deferred compensation account of Mr. Eric
Brandt.
COMPENSATION
DISCUSSION AND ANALYSIS
Human
Resources Committee
The Human Resources Committee of the Board of Directors (the
Committee) administers the Companys executive
compensation program. The role of the Committee is to oversee
DENTSPLYs compensation plans and
15
policies, administer its stock plans (including reviewing and
approving equity grants to executive officers) and annually
review and approve all compensation decisions relating to
executive officers, including those for the Chief Executive
Officer (CEO) and the other executive officers named
in the Summary Compensation Table (the Named Executive
Officers). The Committee reviews its decisions regarding
compensation for the CEO with the Board, and if it determines
appropriate, seeks ratification by the Board.
The Committee is assisted in its work by the Companys
Corporate Human Resources Department. In addition, the Committee
engages an independent compensation consultant, Towers Perrin,
to advise on matters related to CEO and other executive
compensation.
General
Compensation Philosophy
The Committee believes that compensation paid to executive
officers should be competitive with the market, be aligned with
the performance of the Company on both a short-term and
long-term basis, take into consideration individual performance
of the executive and that such compensation should assist the
Company in attracting and retaining key executives critical to
the Companys long-term success. The Companys base
pay and benefit programs provide basic economic security for our
employees at a level consistent with competitive practices to
help retain a highly skilled and qualified workforce. The annual
and long-term incentive compensation programs are designed to
reward performance measured against goals and standards
established by the Committee, and to encourage executives to
increase shareowner value by focusing on growth in revenue and
earnings, generation of cash flow and efficient deployment of
capital, as well as increasing the Companys stock price.
In furtherance of these objectives, the Committee has determined
that the total compensation program for executive officers
should consist of the following components:
|
|
|
|
|
Base Salaries
|
|
|
|
Annual Incentive awards
|
|
|
|
Long-term incentive compensation
|
|
|
|
Retirement, Health & Welfare benefits
|
The executive compensation program in general is intended to
reward executive officers for individual performance and
performance of the Company relative to objectives established by
the Committee. In establishing the Companys current
executive compensation policies, compensation programs and
awards, the Committee reviewed, for purposes of market
comparison, the levels of current compensation at companies
which have similar attributes as the Company using compensation
surveys provided by Towers Perrin, an independent compensation
consultant. The database used by Towers Perrin is comprised of
196 comparator companies generating annual revenues of
$1 billion to $3 billion (Peer Group).
This data from the Peer Group is considered by the Committee in
determining the proportions of base pay, annual incentive pay
and long-term compensation, as well as the targeted total
compensation value. In reviewing executive officers
compensation, the Committee also considers recommendations from
the CEO regarding total compensation for executive officers. The
compensation consultant provides to the Committee historical and
prospective total compensation components for each executive
officer as compared to the Peer Group. Base pay and annual
incentives are targeted to a range around the
50th percentile,
and long-term incentives are targeted to a range around the
75th percentile
of the Peer Group, subject to individual performance and
experience factors of the executive officers. The Committee does
not consider the overall wealth accumulation or prior
compensation of executives in establishing the current level of
compensation, except to the extent the prior compensation is
considered in the comparative analysis described above.
Base
Salaries and Annual Incentive Awards
Base Salaries reflect the external market value of a particular
role as well as the experiences and qualifications that an
individual brings to the role. The primary purpose of the Base
Salaries is to pay a fair, market competitive rate in order to
attract and retain key executives. Base Salaries are targeted to
a range around the
50th percentile
of the base pay paid by the Peer Group for a comparative role,
in order to ensure that the Company is able to compete in the
market for outstanding employees without unduly emphasizing
fixed compensation. The starting point for the Committee in
establishing Base Salaries and Annual Incentive awards is to
review the total annual cash
16
compensation of the executive officers with the total annual
cash compensation for comparable positions in the Peer Group. In
determining the total annual cash compensation of the executive
officer, the Committee establishes a comparative Base Salary and
what the Annual Incentive awards would be at the 100% target
achievement level. Once the Committee establishes the
appropriate range for Base Salaries relative to comparable
positions reflected in the Peer Group, the Committee adjusts the
Base Salary of the individual executive officer based on
consideration of several factors, including individual
performance, Company performance, the experience level of the
executive, the nature and breadth of the executives
responsibilities, and the desire to retain and risk of losing
the services of the executive to another company. The Base
Salaries of executive officers are generally reviewed by the
Committee in the fourth quarter of each year in connection with
the review of total compensation and changes are made effective
at the beginning of the following year.
Annual
Incentive Awards
The Committee believes it is important to have a portion of
total annual cash compensation tied to the short-term (annual)
performance of the Company and its executives. It is intended
that this component of the total compensation of executives be
competitive with the market, but also reward executives for good
performance. The Committee believes this helps to align the
compensation and objectives of the executives with the Company
and its shareholders. The Committee annually reviews and
establishes targets for annual bonus payouts to be applicable
for the performance year. These targets are generally
established in the fourth quarter of the year preceding or at
the beginning of the performance year. In establishing the
target payouts, the Committee evaluates the compensation levels
in the Peer Group. The Committee establishes performance targets
for the executive officers, which if achieved at the 100% level
would result in annual bonuses that, in combination with Base
Salary, are competitive in the 50th percentile range with
the total annual compensation of comparable positions in the
Peer Group. If the Company exceeds the targets established by
the Committee, the annual bonus payouts will exceed the
50th percentile and if the Company falls below the targets,
the annual bonuses will be less than the 50th percentile of
the Peer Group. The general principle in setting targets and
measuring performance are that management is responsible and
accountable for results as measured based on U. S. GAAP,
consistently applied, however, the Committee may adjust the
targets or the payouts in its discretion to address unique or
significant events, such as the impact of merger and acquisition
activity, charges related to settlement of litigation, asset
write-downs and unbudgeted restructuring expenses or gains, and
the impact of significant or non-recurring unbudgeted one-time
gains or losses, that are either outside the control of
management, are not reflective of current operations, or benefit
future periods.
Annual incentive awards are determined as a percentage of each
executives base salary. The Committee determines the
performance measures and other terms and conditions of awards
for executives covered under the Companys Annual Incentive
program. Performance measures include targets for net income,
sales growth for the Company and, in the case of operating
executives who have responsibility for certain businesses, the
net income and sales growth of those businesses. The Committee
believes that employees in higher ranks should have a higher
proportion of their total compensation delivered through
pay-for-performance
cash incentives and long-term equity compensation; as a result,
their total compensation will be more significantly correlated,
both upward and downward, to DENTSPLYs financial
performance and stock price performance. For example, the
CEOs annual incentive award at the target level is 100% of
base salary and the COOs annual incentive award at the
target level is 75% of base salary. The variability of the cash
compensation of the Companys executives is closely linked
to annual financial results, delivering
lower-than-market
total cash compensation in times of poor financial performance.
Conversely, in times of excellent performance, compensation
variability yields higher total cash compensation, rewarding the
executives for such performance. The Annual Incentive payments
are not directly linked to DENTSPLYs stock price
performance. For 2006, the bonus targets for executives ranged
from 50% to 100% of Base Salary depending on the
executives position.
Long-Term
Incentive Compensation
The Committee believes that long-term incentive compensation
performs an essential role in attracting and retaining senior
executives and providing them long-term incentives to maximize
shareholder value. Historically, DENTSPLY has relied primarily
on stock options for its long-term incentive program. A stock
option becomes valuable only if DENTSPLYs stock price
increases above the option exercise price and the holder of the
option
17
remains employed for the period required for the option to vest.
This provides an incentive for an option holder to remain
employed by DENTSPLY and to maximize shareholder value. The
Committee believes that equity-based compensation ensures that
the Companys executive officers have a continuing stake in
the long-term success of the Company and is most closely aligned
with the interest of shareholders. For this reason, the
Committee has placed more emphasis and weight on the long-term
equity incentive portion of the total compensation of
executives, targeting the equity incentive compensation at a
range around the 75th percentile of the Peer Group. If
shareholder value grows through appreciation of the stock price,
the compensation of the Companys executives will reflect
that stock performance. Historically, the Companys equity
incentive has been comprised of stock options which are granted
at the Board meeting in December of each year as well as to
newly hired executives at the Committee meeting which follows
the executives employment date, at the closing price on
the day of the grant. Accordingly, those stock options will have
value only if the market price of the Companys common
stock increases after that date.
During 2006, the Committee reviewed the use and value of the
equity program with respect to executive officer compensation
programs. The Committee retained Towers Perrin to assist with
this review. Working with Towers Perrin, the Committee did a
comprehensive review and evaluation of current market practices
with respect to equity compensation. In this review, the
Committee considered the new accounting requirement that
companies expense stock option grants and the changing
perceptions of the advantages and disadvantages of stock option
based equity compensation. As a result of this review, the
Committee decided to utilize, beginning in 2007, restricted
stock units (RSUs), as part of the Companys
equity incentive program, in addition to stock options. The
Committee believes that the use of RSUs as part of the
Companys equity compensation program is more consistent
with current market practices, provides a greater opportunity
for executives to build share ownership in the Company and
provides an equity vehicle that allows DENTSPLY to attract,
motivate and retain the employee talent considered critical for
achieving the Companys goals.
In determining the size of equity incentive grants to executive
officers, the Committee targets a range around the
75th percentile
of the Peer Group companies for persons holding comparable
positions. The Committee then takes into consideration the
Companys performance against the strategic plan, and
individual performance against the individuals objectives,
as well as the allocation of overall share usage attributed to
executive officers. With respect to the number of RSUs granted,
the Committee focuses, in particular, on the performance of the
Company over the prior three years. For stock option grants in
December 2006 and grants of RSUs in 2007, seventy percent of the
value was converted to a number of stock options using an
estimated Black-Scholes value, and the remaining 30% of value
was converted to RSUs on the basis of a restricted stock unit
deemed to be equivalent in value to three stock options. The
split between stock options and RSUs was based both on
comparisons to the market and the overall risk/reward tradeoff,
with stock options providing compensation based solely upon
increases in the Companys stock price and RSUs providing
compensation based both upon accomplishment of corporate
performance goals as well as enhancement of the stock value.
Equity
Grant Practices
The Committee reviewed the Companys practices for equity
incentive grants. The grant date utilized for annual and other
grants is always on the date the Committee or the Board approves
the grants. Stock options are granted with an exercise price
equal to the closing price on the day of the grant.
Total
Compensation
The Company intends to continue its strategy of compensating its
executives through programs that recognize market conditions and
emphasize performance-based incentive compensation. To that end,
executive compensation is structured to ensure that there is an
appropriate balance between the long-term and short-term
performance of the Company, and also a balance between Company
financial performance and shareholder return. For 2006, the
actual total compensation of the Named Executive Officers was
approximately 24% above the median of total compensation paid to
executives holding equivalent positions in the Peer Group. The
Committee believes that this position was consistent with the
experience level of the Companys executives, the
Companys financial performance and the performance of each
of the Named Executive Officers.
18
Post
Termination Arrangements
The Company has entered employment agreements with all of the
Named Executive Officers. Each of these employment agreements
provides that, upon termination of such individuals
employment with the Company as a result of the employees
death, the Company is obligated to pay the employees
estate the then current base compensation of the employee for a
period of one year following the date of the employees
death, together with the employees pro rata share of any
incentive or bonus payments for the period prior to the
employees death in the year of such death. Each of the
employment agreements also provides that, in the event that the
employees employment is terminated by the Company without
cause, or by the employee with good reason, (i) the Company
will be obligated to pay the employee for a period of two years
subsequent to termination of employment all compensation at the
rate paid and in the term paid to the employee during the prior
12 month period, and (ii) the employee will be
entitled to receive the benefits that would have been accrued by
him during the two-year period following termination of
employment under employee benefit plans, programs or other
arrangements of the Company or any of its affiliates in which
the employee participated before the termination of employment.
In the event that such termination of employment is made by the
Company without cause or by the employee with good reason after
a change in control of the Company, the employee may require the
Company to pay to the employee, within five days after the
employees request for such payment, the present value of
the amounts that would have been payable to him under the
employment agreement during the two-year period following such
termination of employment.
Retirement
and Other Benefits
DENTSPLY offers retirement benefits to its U.S. employees
through tax-qualified plans, including an employee and
employer-funded 401(k) Savings Plan and a discretionary
company-funded Employee Stock Ownership Plan (ESOP).
The Committee allows for the participation of the executive
officers in these plans, and the terms governing the retirement
benefits under these plans for the executive officers are the
same as those available for other eligible employees in the
U.S. Similarly situated employees, including
DENTSPLYs executive officers, may have materially
different account balances because of a combination of factors:
the number of years that the person has participated in the
plan; the amount of money contributed, and the investments
chosen by the participant with regard to those plans providing
for participant investment direction. These plans do not involve
any guaranteed minimum returns or above-market returns; the
investment returns are dependent upon actual investment results.
Employees direct their own investments in the 401(k) Savings
Plan. The ESOP is a defined contribution plan designed to allow
employees to accumulate retirement accounts through ownership of
Company stock, including executive officers, and to allow
DENTSPLY to make contributions or allocations to those funds.
Effective January 1, 1999, the Board of Directors of the
Company adopted a Supplemental Executive Retirement Plan (the
Plan). The purpose of the Plan is to provide
additional retirement benefits for a limited group of management
employees, including the named executive officers, whom the
Board concluded were not receiving competitive retirement
benefits. The Committee annually approves participants in the
Plan. Contributions equal to 11.7% of total annual compensation,
reduced by ESOP contributions, are allocated to the
participants accounts. No actual benefits are put aside
for participants and the participants are general creditors of
the Company for payment of the benefits upon retirement or
termination from the Company. Participants can elect to have
these benefits administered as savings with interest or stock
unit accounts, with stock units being distributed in the form of
Common stock at the time of distribution. Upon retirement or
termination for any reason, participants in the Supplemental
Executive Retirement Plan are paid the benefits in their account
based on an earlier distribution election.
DENTSPLYs healthcare, insurance, and other welfare and
employee-benefit programs are the same for all eligible
employees, including executive officers. DENTSPLY shares the
cost of health and welfare benefits with its employees, a cost
that is dependent on the level of benefits coverage that each
employee elects. The Company also provides other benefits such
as medical, dental and life insurance to each Named Executive
Officer, in a similar fashion to those provided to all other
U.S.-based
DENTSPLY employees.
19
Stock
Ownership Program
Because the Committee believes in further linking the interests
of management and the shareholders, the Company maintains stock
ownership guidelines for its executives. The guidelines specify
the number of shares that DENTSPLYs executive management
should accumulate and hold within six (6) years of the date
of appointment to the executive position. Stock
ownership is defined to include stock owned by the officer
directly, stock owned indirectly through the Companys
retirement Plans, and stock awarded pursuant to the equity
incentive program, other than stock options, and subsequently
deferred. Under the current guideline established by the
Committee, executives are required to own Company common stock
equal in value to a multiple of their Base Salary, as set forth
below:
|
|
|
|
|
Chief Executive Officer
|
|
|
5X
|
|
Chief Operating Officer
|
|
|
3X
|
|
Senior Vice Presidents
|
|
|
2X
|
|
Vice Presidents
|
|
|
1X
|
|
Tax
Deductibility of Executive Compensation
Section 162(m) of the Internal Revenue Code of 1986, as
amended (the Tax Code), places a limit of $1,000,000
on the amount of compensation that the Company may deduct in any
one year with respect to the Named Executive Officers. There is
an exception to the $1,000,000 limitation for performance-based
compensation meeting certain requirements. Stock options
generally are performance-based compensation meeting those
requirements, and, as such, are fully deductible. To maintain
flexibility in compensating executive officers in a manner
designed to promote varying corporate goals, the Committee has
not adopted a policy requiring all compensation to be
deductible. The Committee has established a performance goal for
the Chief Executive Officer, Chief Operating Officer and Chief
Financial Officer for the vesting of their RSUs granted in 2007,
requiring the Company to be profitable over the three year
vesting period, consistent with the performance based
requirements established by 162(m).
Adoption
of Compensation Discussion and Analysis
The Human Resources Committee has reviewed and discussed the
Compensation Discussion and Analysis required by
Item 402(b) of SEC
Regulation S-K
with management and, based on such review and discussions, the
Human Resources Committee recommended to the Board of Directors
that the Compensation Discussion and Analysis be included in
this proxy statement.
This report was adopted on February 14, 2007 by the Human
Resources Committee of the Board of Directors:
William F. Hecht
Michael C. Alfano
Michael J. Coleman
W. Keith Smith
HUMAN
RESOURCES COMMITTEE REPORT ON EXECUTIVE COMPENSATION
The Human Resources Committee is comprised of four directors,
all of whom are independent under the Listing Standards and
operates under a written charter (a copy of the Human Resources
Committee Charter is attached to this Proxy Statement as
Appendix D). The Committee is pleased to present its report
on executive compensation. This report describes the components
of the Companys executive officer compensation programs
and the basis on which compensation determinations are made with
respect to the executive officers of the Company.
The Compensation Committee has reviewed and discussed with
management the Companys Compensation Discussion and
Analysis section of this Proxy Statement. Based on such review
and discussions, the Committee has recommended to the Board of
Directors that the Compensation Discussion and Analysis be
included in this Proxy Statement. The Compensation Discussion
and Analysis is incorporated by reference into the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2006.
HUMAN RESOURCES COMMITTEE
|
|
|
|
|
|
|
William
F. Hecht
|
|
Michael
C. Alfano
|
|
Michael
J. Coleman
|
|
W. Keith
Smith
|
20
EXECUTIVE
COMPENSATION
Summary
Compensation
The following table sets forth the compensation earned by the
named executive officers for the fiscal year ended
December 31, 2006. The named executive officers are the
Companys chief executive officer, chief financial officer,
and three other most highly compensated executive officers
ranked in the table below by their total compensation.
Summary
Compensation Table
For Fiscal Year End December 31, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in Pension
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Option
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
|
|
|
|
|
Salary
|
|
|
Bonus
|
|
|
Awards
|
|
|
Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
Name and Principle Position(1)
|
|
Year
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)(7)
|
|
|
($)(8)
|
|
|
($)
|
|
|
($)(9)
|
|
|
($)
|
|
|
Gerald K. Kunkle, Jr.
|
|
|
2006
|
|
|
|
800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
748,800
|
|
|
|
|
|
|
|
160,759
|
|
|
|
1,709,559
|
|
Chairman of the Board and Chief
Executive Officer (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William R. Jellison
|
|
|
2006
|
|
|
|
368,000
|
|
|
|
|
|
|
|
|
|
|
|
328,742
|
|
|
|
189,400
|
|
|
|
|
|
|
|
61,733
|
|
|
|
947,875
|
|
Senior Vice President and Chief
Financial Officer (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bret W. Wise
|
|
|
2006
|
|
|
|
477,000
|
|
|
|
|
|
|
|
|
|
|
|
1,526,909
|
|
|
|
334,900
|
|
|
|
|
|
|
|
64,280
|
|
|
|
2,403,089
|
|
President and Chief Operating
Officer (4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher T. Clark
|
|
|
2006
|
|
|
|
330,000
|
|
|
|
|
|
|
|
|
|
|
|
549,966
|
|
|
|
204,200
|
|
|
|
|
|
|
|
49,573
|
|
|
|
1,133,739
|
|
Senior Vice President (5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian M. Addison
|
|
|
2006
|
|
|
|
318,000
|
|
|
|
|
|
|
|
|
|
|
|
215,036
|
|
|
|
148,800
|
|
|
|
|
|
|
|
47,643
|
|
|
|
729,479
|
|
Vice President, Secretary and
General Counsel (6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Principal positions reflect positions held during 2006. |
|
(2) |
|
Mr. Kunkle was appointed Chairman of the Board effective
May 11, 2005. Effective December 31, 2006,
Mr. Kunkle retired as Chairman of the Board and Chief
Executive Officer of the Company. |
|
(3) |
|
Mr. Jellison served as Senior Vice President, Chief
Financial Officer from April 20, 1998 to October 12,
2004, then served as a Senior Vice President in charge of an
operating unit and was reappointed Senior Vice President and
Chief Financial Officer January 10, 2005. |
|
(4) |
|
Mr. Wise was appointed President and Chief Operating
Officer effective January 1, 2006. Mr. Wise was named
Chairman of the Board, Chief Executive Officer and President of
the Company effective January 1, 2007. |
|
(5) |
|
Mr. Clark was appointed Senior Vice President effective
January 1, 2003. Mr. Clark was named Executive Vice
President and Chief Operating Officer of the Company effective
January 1, 2007. |
|
(6) |
|
Mr. Addison was appointed Vice President, Secretary and
General Counsel effective January 1, 1998. |
|
(7) |
|
Represents the compensation costs of stock options recognized in
2006 for financial statement reporting purposes in accordance
with Financial Accounting Standard No. 123(R), using the
Black-Scholes option pricing model. Assumptions used in the
calculation of these amounts for fiscal year ended
December 31, 2006 are included in Note 12 to the
Companys Consolidated Financial Statements. |
|
(8) |
|
Amounts shown represent Incentive Compensation Plan earnings for
services provided in 2006 that were paid in cash in 2007. There
were no earnings on outstanding non-equity incentive plan awards. |
|
(9) |
|
Amounts shown are described in the following 2006 All Other
Compensation table. |
Refer to the Compensation Discussion and Analysis section for a
complete description of the components of compensation, along
with a description of the material terms and conditions of each
component.
For the named executive officers, salary compensation as a
percentage of total compensation are as follows:
Mr. Kunkle 47.2%, Mr. Jellison
39.4%, Mr. Wise 19.8%,
Mr. Clark 29.1%, and
Mr. Addison 43.6%
21
Grants
of
Plan-Based Awards
The following table reflects the terms of compensation
plan-based awards granted to named executive officers in 2006.
2006
Grants of Plan-Based Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Other
|
|
All Other
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
Exercise
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Awards:
|
|
or
|
|
|
|
|
Estimated Future Payouts Under
|
|
Estimated Future Payouts
|
|
Number of
|
|
Number of
|
|
Base
|
|
|
|
|
Non-Equity Incentive Plan
|
|
Under Equity Incentive Plan
|
|
Securities
|
|
Securities
|
|
Price of
|
|
|
|
|
Awards(1)
|
|
Awards
|
|
Underlying
|
|
Underlying
|
|
Option
|
|
|
Grant
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Options
|
|
Options(7)
|
|
Awards(8)
|
Name of Executive Officer
|
|
Date
|
|
($)
|
|
($)
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
($/Share)
|
|
Gerald K. Kunkle, Jr.
|
|
|
|
|
|
|
336,000
|
|
|
|
800,000
|
|
|
|
1,232,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William R. Jellison
|
|
|
|
|
|
|
85,008
|
|
|
|
202,400
|
|
|
|
311,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (3)
|
|
|
12/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,500
|
|
|
|
31.36
|
|
Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bret W. Wise
|
|
|
|
|
|
|
150,255
|
|
|
|
357,750
|
|
|
|
550,935
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (4)
|
|
|
12/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
197,400
|
|
|
|
31.36
|
|
Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher T. Clark
|
|
|
|
|
|
|
76,230
|
|
|
|
181,500
|
|
|
|
279,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (5)
|
|
|
12/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71,100
|
|
|
|
31.36
|
|
Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brian M. Addison
|
|
|
|
|
|
|
66,780
|
|
|
|
159,000
|
|
|
|
244,860
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Compensation (6)
|
|
|
12/12/2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,800
|
|
|
|
31.36
|
|
Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts shown represent threshold, target and maximum amounts
for the 2006 Annual Incentive Award compensation plans. The
Human Resources Committee established the targets on
February 3, 2006. Target amounts would be achieved if
budgeted net income and sales growth were achieved. For
instance, Mr. Kunkles target was 100% of his salary
($800,000) if the Company achieved budgeted net income and
budgeted sales growth in 2006. Threshold amounts represent the
least amounts that could be earned under the Incentive
Compensation Plan. The net income factor for obtaining at least
90% of budgeted net income was 60% and the sales growth factor
for achieving at least 81.7% of budgeted sales growth was 70%.
Mr. Kunkles threshold was his base salary ($800,000)
multiplied by his target (100%) multiplied by the minimum net
income factor (60%) multiplied by the minimum sales growth
factor (70%). Maximum amounts represent the greatest amounts
that could be earned under the Incentive Compensation Plan. The
net income factor for obtaining 110% or more of budgeted net
income was 140% and the sales growth factor for achieving 116.7%
of budgeted sales growth was 110%. Mr. Kunkles
maximum was his base salary ($800,000) multiplied by his target
(100%) multiplied by the maximum net income factor (140%)
multiplied by the maximum sales growth factor (110%). Payments
of Annual Incentive Award compensation plans are shown in the
Non-Equity Incentive Plan Compensation column of the 2006
Summary Compensation Table. Refer to the Compensation Discussion
and Analysis for a description of the criteria for payment of
Annual Incentive Awards. |
|
(2) |
|
Mr. Kunkles incentive compensation target was
calculated at 100% of his base salary. |
|
(3) |
|
Mr. Jellisons incentive compensation target was
calculated at 55% of his base salary. |
|
(4) |
|
Mr. Wises incentive compensation target was
calculated at 75% of his base salary. |
|
(5) |
|
Mr. Clarks incentive compensation target was
calculated at 55% of his base salary. |
|
(6) |
|
Mr. Addisons incentive compensation target was
calculated at 50% of his base salary |
|
(7) |
|
Amounts shown are the number of stock options granted to the
named officers in 2006. Refer to the Compensation Discussion and
Analysis for a description of the terms of and criteria for
making these awards. |
|
(8) |
|
Price reflects the closing price of DENTSPLY International
common stock on the date the Board of Directors approved the
grant. |
The grant date of annual and other grants is always on the date
the Human Resources Committee or the Board of Directors approves
the grants. Stock options are granted with an exercise price
equal to the closing price on the day of the grant.
22
Outstanding
Equity Awards at Year End
The following table reflects the number and terms of stock
option awards and stock awards outstanding as of
December 31, 2006 for the named executive officers.
Outstanding
Equity Awards at Fiscal Year End
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Market or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Payout
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Unearned
|
|
|
Unearned
|
|
|
|
|
|
|
Number of
|
|
|
Plan Awards:
|
|
|
|
|
|
|
|
|
|
|
|
Value of
|
|
|
Shares,
|
|
|
Shares,
|
|
|
|
Number of
|
|
|
Securities
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Shares or
|
|
|
Units or
|
|
|
Units or
|
|
|
|
Securities
|
|
|
Underlying
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Shares or
|
|
|
Units of
|
|
|
Other
|
|
|
Other
|
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
Underlying
|
|
|
Option
|
|
|
|
|
|
Units of Stock
|
|
|
Stock
|
|
|
Rights
|
|
|
Rights
|
|
|
|
Unexercised
|
|
|
Options
|
|
|
Unexercised
|
|
|
Exercise
|
|
|
Option
|
|
|
That
|
|
|
That
|
|
|
That
|
|
|
That
|
|
|
|
Options
|
|
|
(Unexercisable)
|
|
|
Unearned
|
|
|
Price
|
|
|
Expiration
|
|
|
Have Not
|
|
|
Have Not
|
|
|
Have Not
|
|
|
Have Not
|
|
|
|
(Exercisable)
|
|
|
(#)
|
|
|
Options
|
|
|
($)
|
|
|
Date
|
|
|
Vested
|
|
|
Vested
|
|
|
Vested
|
|
|
Vested
|
|
Name
|
|
(#)
|
|
|
(1)
|
|
|
(#)
|
|
|
(2)
|
|
|
(3)
|
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Gerald K. Kunkle, Jr.
|
|
|
316,744
|
|
|
|
|
|
|
|
|
|
|
|
27.74
|
|
|
|
12/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
266,234
|
|
|
|
|
|
|
|
|
|
|
|
27.45
|
|
|
|
12/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
132,200
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
12/31/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
715,178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William R. Jellison
|
|
|
56,700
|
|
|
|
|
|
|
|
|
|
|
|
9.29
|
|
|
|
5/19/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101,100
|
|
|
|
|
|
|
|
|
|
|
|
12.48
|
|
|
|
12/13/2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78,300
|
|
|
|
|
|
|
|
|
|
|
|
15.58
|
|
|
|
12/12/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,000
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
12/11/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
12/15/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,891
|
|
|
|
13,945
|
|
|
|
|
|
|
|
27.45
|
|
|
|
12/13/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,733
|
|
|
|
13,467
|
|
|
|
|
|
|
|
26.69
|
|
|
|
3/22/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,145
|
|
|
|
48,289
|
|
|
|
|
|
|
|
27.74
|
|
|
|
12/13/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
42,500
|
|
|
|
|
|
|
|
31.36
|
|
|
|
12/12/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
423,469
|
|
|
|
118,201
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bret W. Wise
|
|
|
109,000
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
12/11/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
12/15/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,569
|
|
|
|
20,285
|
|
|
|
|
|
|
|
27.45
|
|
|
|
12/13/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,361
|
|
|
|
120,723
|
|
|
|
|
|
|
|
27.74
|
|
|
|
12/13/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
197,400
|
|
|
|
|
|
|
|
31.36
|
|
|
|
12/12/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
269,530
|
|
|
|
338,408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher T. Clark
|
|
|
23,700
|
|
|
|
|
|
|
|
|
|
|
|
7.63
|
|
|
|
12/8/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,800
|
|
|
|
|
|
|
|
|
|
|
|
12.48
|
|
|
|
12/13/2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,900
|
|
|
|
|
|
|
|
|
|
|
|
15.58
|
|
|
|
12/12/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,000
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
12/11/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
59,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
12/15/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,891
|
|
|
|
13,945
|
|
|
|
|
|
|
|
27.45
|
|
|
|
12/13/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18,347
|
|
|
|
36,695
|
|
|
|
|
|
|
|
27.74
|
|
|
|
12/13/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
71,100
|
|
|
|
|
|
|
|
31.36
|
|
|
|
12/12/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
240,238
|
|
|
|
121,740
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
|
Market or
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
|
Payout
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Value of
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
|
Market
|
|
|
Unearned
|
|
|
Unearned
|
|
|
|
|
|
|
Number of
|
|
|
Plan Awards:
|
|
|
|
|
|
|
|
|
|
|
|
Value of
|
|
|
Shares,
|
|
|
Shares,
|
|
|
|
Number of
|
|
|
Securities
|
|
|
Number of
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Shares or
|
|
|
Units or
|
|
|
Units or
|
|
|
|
Securities
|
|
|
Underlying
|
|
|
Securities
|
|
|
|
|
|
|
|
|
Shares or
|
|
|
Units of
|
|
|
Other
|
|
|
Other
|
|
|
|
Underlying
|
|
|
Unexercised
|
|
|
Underlying
|
|
|
Option
|
|
|
|
|
|
Units of Stock
|
|
|
Stock
|
|
|
Rights
|
|
|
Rights
|
|
|
|
Unexercised
|
|
|
Options
|
|
|
Unexercised
|
|
|
Exercise
|
|
|
Option
|
|
|
That
|
|
|
That
|
|
|
That
|
|
|
That
|
|
|
|
Options
|
|
|
(Unexercisable)
|
|
|
Unearned
|
|
|
Price
|
|
|
Expiration
|
|
|
Have Not
|
|
|
Have Not
|
|
|
Have Not
|
|
|
Have Not
|
|
|
|
(Exercisable)
|
|
|
(#)
|
|
|
Options
|
|
|
($)
|
|
|
Date
|
|
|
Vested
|
|
|
Vested
|
|
|
Vested
|
|
|
Vested
|
|
Name
|
|
(#)
|
|
|
(1)
|
|
|
(#)
|
|
|
(2)
|
|
|
(3)
|
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Brian M. Addison
|
|
|
35,400
|
|
|
|
|
|
|
|
|
|
|
|
8.31
|
|
|
|
12/10/2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,400
|
|
|
|
|
|
|
|
|
|
|
|
7.63
|
|
|
|
12/8/2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,500
|
|
|
|
|
|
|
|
|
|
|
|
12.48
|
|
|
|
12/13/2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,200
|
|
|
|
|
|
|
|
|
|
|
|
15.58
|
|
|
|
12/12/2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,600
|
|
|
|
|
|
|
|
|
|
|
|
18.49
|
|
|
|
12/11/2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,600
|
|
|
|
|
|
|
|
|
|
|
|
22.14
|
|
|
|
12/15/2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,805
|
|
|
|
10,903
|
|
|
|
|
|
|
|
27.45
|
|
|
|
12/13/2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,687
|
|
|
|
31,375
|
|
|
|
|
|
|
|
27.74
|
|
|
|
12/13/2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,800
|
|
|
|
|
|
|
|
31.36
|
|
|
|
12/12/2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
274,192
|
|
|
|
70,078
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Options granted become exercisable over a period of three years
after the date of grant at the rate of one-third per year,
except that they become immediately exercisable upon death,
disability or qualified retirement. Options generally expire ten
years after the date of grant under these plans. The
unexercisable stock options with the following expiration dates
will vest as indicated below: |
|
|
|
Expiration Date
|
|
Vesting Schedules
|
|
12/13/2014
|
|
Remaining one third will vest
December 13, 2007
|
3/22/2015
|
|
One third will vest on
March 22, 2007; the remaining one third will vest
March 22, 2008
|
12/13/2015
|
|
One third will vest on
December 13, 2007; the remaining one third will vest
December 13, 2008
|
12/12/2016
|
|
One third will vest
December 12, 2007, an additional one third will vest
December 12, 2008; the remaining one third will vest
December 12, 2009
|
|
|
|
(2) |
|
The Companys stock options are granted at the Board
meeting in December of each year as well as to newly hired
executives at the Committee meeting which follows the
executives employment date, at the closing price on the
day of the grant. |
|
(3) |
|
Stock options expire ten years after the grant date |
All
Other Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ESOP Stock
|
|
|
401(k)
|
|
|
SERP
|
|
|
Perquisites >
|
|
|
Total Other
|
|
|
|
Contribution
|
|
|
Contribution
|
|
|
Contribution
|
|
|
$10,000
|
|
|
Compensation
|
|
Name of Executive Officer
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)(4)
|
|
|
($)
|
|
|
Gerald K. Kunkle, Jr.
|
|
|
1,835
|
|
|
|
6,600
|
|
|
|
136,306
|
|
|
|
16,018
|
|
|
|
160,759
|
|
William R. Jellison
|
|
|
1,835
|
|
|
|
6,600
|
|
|
|
40,413
|
|
|
|
12,886
|
|
|
|
61,733
|
|
Bret W. Wise
|
|
|
1,835
|
|
|
|
6,600
|
|
|
|
55,845
|
|
|
|
|
|
|
|
64,280
|
|
Christopher T. Clark
|
|
|
1,835
|
|
|
|
6,600
|
|
|
|
41,138
|
|
|
|
|
|
|
|
49,573
|
|
Brian M. Addison
|
|
|
1,835
|
|
|
|
6,600
|
|
|
|
39,208
|
|
|
|
|
|
|
|
47,643
|
|
|
|
|
(1) |
|
Represents the cost basis of allocations to each of the Named
Executive Officers DENTSPLY Employee Stock Ownership Plan (ESOP)
balances for the year ended
12/31/2006.
Pursuant to the terms of the ESOP Plan, non- |
24
|
|
|
|
|
vested ESOP shares forfeited by terminated employees, and
dividends earned on the forfeited shares, are redistributed to
the current ESOP participants, thus reducing the companys
contribution requirement. The ESOP is a non-contributory defined
contribution plan |
|
(2) |
|
Represents the non-elective cash contributions by the Company
into a 401(k) savings plan for each of the Named Executive
Officers. |
|
(3) |
|
Company credits to the DENTSPLY International Supplemental
Executive Retirement Plan; a non-contributory retirement plan
for a select group of management
and/or
highly compensated employees. Additional information is provided
in the Non-Qualified Deferred Compensation section. |
|
(4) |
|
The value of flights on a private plane for personal use. |
Option
Exercises and Stock Vested
The following table sets forth certain information with respect
to the exercise of options and stock vested during the year
ended December 31, 2006 and the value of options held at
that date.
Option
Exercises and Stock Vested
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards
|
|
|
Stock Awards
|
|
|
|
Number of
|
|
|
Value
|
|
|
Number of
|
|
|
Value
|
|
|
|
Shares Acquired
|
|
|
Realized on
|
|
|
Shares Acquired
|
|
|
Realized on
|
|
|
|
on Exercise
|
|
|
Exercise
|
|
|
on Vesting
|
|
|
Vesting
|
|
Name
|
|
(#)
|
|
|
($)
|
|
|
(#)
|
|
|
($)
|
|
|
Gerald K. Kunkle, Jr.
|
|
|
1,408,700
|
|
|
|
23,086,084
|
|
|
|
|
|
|
|
|
|
William R. Jellison
|
|
|
111,300
|
|
|
|
2,490,778
|
|
|
|
|
|
|
|
|
|
Bret W. Wise
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher T. Clark
|
|
|
16,200
|
|
|
|
347,354
|
|
|
|
|
|
|
|
|
|
Brian M. Addison
|
|
|
24,000
|
|
|
|
494,356
|
|
|
|
|
|
|
|
|
|
Non-Qualified
Deferred Compensation
Effective January 1, 1999, the Board of Directors of the
Company adopted a Supplemental Executive Retirement Plan (the
Plan). The purpose of the Plan is to provide
additional retirement benefits for a limited group of management
employees, including the named executive officers, whom the
Board concluded were not receiving competitive retirement
benefits. Contributions equal to 11.7% of compensation reduced
by ESOP contributions are allocated to the participants
accounts. No actual benefits are put aside for participants and
the participants are general creditors of the Company for
payment of the benefits upon retirement or termination from the
Company. Participants can elect to have these benefits
administered as savings with interest or stock unit accounts,
with stock units being distributed in the form of Common stock
at the time of distribution.
Upon retirement or termination for any reason, participants in
the Supplemental Executive Retirement Plan are paid the benefits
in their account based on an earlier election to have their
accounts distributed immediately or in annual installments for
up to five (5) years.
In the event of a participants death before his or her
account has been distributed, distribution shall be made to the
beneficiary selected by the participant within thirty
(30) days after the date of death (or, if later, after the
proper beneficiary has been identified.)
In the event of a change in control as defined in this Plan,
participants will be given the option to receive the value of
their accounts in lump sums no later than sixty (60) days
after the Change in Control. Optional distributions received
subject to a change in control must represent the entire
Supplemental Executive Retirement Accounts and will be subject
to five percent (5%) penalty reductions.
All distributions under this Plan shall be based upon the amount
credited to a participants account as of the last business
day of the month immediately preceding the date of the
distribution. The amount of installments payable to a
participant electing distribution through installments shall be
determined by dividing the amount credited to the
participants vested account by the remaining number of
installments, including the current installment, to be paid.
25
It is understood that administrative or legal requirements may
lead to a delay between such valuation date and the date of
distribution.
The following table sets forth contributions, earnings and
year-end balances for 2006 with respect to
non-qualified
deferred compensation plans for the Named Executive Officers.
Non-Qualified
Deferred Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
|
Registrant
|
|
|
Aggregate
|
|
|
|
|
|
Aggregate
|
|
|
|
|
|
Contributions
|
|
|
Contributions
|
|
|
Earnings in
|
|
|
Aggregate
|
|
|
Balance at
|
|
|
|
|
|
in Last
|
|
|
in Last
|
|
|
Last
|
|
|
Withdrawals/
|
|
|
Last Fiscal
|
|
|
|
|
|
Fiscal Year
|
|
|
Fiscal Year
|
|
|
Fiscal Year
|
|
|
Distributions
|
|
|
Year-End
|
|
Name
|
|
Plan Name
|
|
($)(1)
|
|
|
($)(2)
|
|
|
($)(3)
|
|
|
($)(4)
|
|
|
($)(5)
|
|
|
Gerald K. Kunkle, Jr.
|
|
Supplemental Executive Retirement
Plan
|
|
|
0
|
|
|
|
136,306
|
|
|
|
130,793
|
|
|
|
0
|
|
|
|
1,048,132
|
|
William R. Jellison
|
|
Supplemental Executive Retirement
Plan
|
|
|
0
|
|
|
|
40,413
|
|
|
|
53,788
|
|
|
|
0
|
|
|
|
441,396
|
|
Bret W. Wise
|
|
Supplemental Executive Retirement
Plan
|
|
|
0
|
|
|
|
55,845
|
|
|
|
31,455
|
|
|
|
0
|
|
|
|
215,532
|
|
Christopher T. Clark
|
|
Supplemental Executive Retirement
Plan
|
|
|
0
|
|
|
|
41,138
|
|
|
|
30,277
|
|
|
|
0
|
|
|
|
232,982
|
|
Brian M. Addison
|
|
Supplemental Executive Retirement
Plan
|
|
|
0
|
|
|
|
39,208
|
|
|
|
33,388
|
|
|
|
0
|
|
|
|
263,783
|
|
|
|
|
(1) |
|
Participants in the Supplemental Executive Retirement Plan
cannot contribute to the plan. |
|
(2) |
|
Amounts represent unfunded credits allocated to
participants accounts in 2006. They are reported on the
participants 2006 IRS
Form W-2
and the All Other Compensation column in the Summary
Compensation Table. |
|
(3) |
|
Participants can elect to have these benefits administered as
savings with interest or stock unit accounts, with stock units
being distributed in the form of Common Stock at the time of
distribution. The amounts represent unfunded interest
and/or
dividend credits allocated to participants accounts in
2006. Earnings are calculated using market rates. For this
reason these amounts are not reported in the All Other
Compensation column in the Summary Compensation Table.
Earnings are not reported to the Internal Revenue Service until
withdrawn. |
|
(4) |
|
There were no distributions to any of the Named Executive
Officers in 2006 |
|
(5) |
|
The amounts reflect the total of all contributions and earnings
credited to the participants accounts as of
December 31, 2006. Contributions earned on 2006 wages are
credited to participants accounts in 2007. |
On February 6, 2007 a lump sum distribution of only
pre-2005 allocations, worth $881,759 was made to Mr. Kunkle
and a further distribution of 4,632 shares worth $138,265
will be made to Mr. Kunkle in July 2007. The table below
discloses possible distributions for the remaining named
executive officers as of December 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination by
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
Termination
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
Not for
|
|
by Employee
|
|
Termination
|
|
after Change in
|
|
|
|
|
|
|
|
|
Retirement
|
|
Cause
|
|
with Cause
|
|
by Company
|
|
Control
|
|
Death
|
|
Disability
|
Name of Officer
|
|
Plan Name
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
William R. Jellison (1)
|
|
Supplemental Executive
Retirement Plan
|
|
|
498,080
|
|
|
|
498,080
|
|
|
|
610,594
|
|
|
|
610,594
|
|
|
|
610,594
|
|
|
|
498,080
|
|
|
|
498,080
|
|
Frequency and
|
|
|
|
|
5 year annual
|
|
|
|
5 year annual
|
|
|
|
5 year annual
|
|
|
|
5 year annual
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Duration of Payment
|
|
|
|
|
installment
|
|
|
|
installment
|
|
|
|
installment
|
|
|
|
installment
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
Bret W. Wise (2)
|
|
Supplemental Executive
Retirement Plan
|
|
|
291,276
|
|
|
|
291,276
|
|
|
|
592,476
|
|
|
|
592,476
|
|
|
|
592,476
|
|
|
|
291,276
|
|
|
|
291,276
|
|
Frequency and
Duration of Payment
|
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
Christopher T. Clark (3)
|
|
Supplemental Executive
Retirement Plan
|
|
|
280,364
|
|
|
|
280,364
|
|
|
|
438,239
|
|
|
|
438,239
|
|
|
|
438,239
|
|
|
|
280,364
|
|
|
|
280,364
|
|
Frequency and
Duration of Payment
|
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
Brian M. Addison (4)
|
|
Supplemental Executive
Retirement Plan
|
|
|
309,177
|
|
|
|
309,177
|
|
|
|
398,958
|
|
|
|
398,958
|
|
|
|
398,958
|
|
|
|
309,177
|
|
|
|
309,177
|
|
Frequency and
|
|
|
|
|
3 year annual
|
|
|
|
3 year annual
|
|
|
|
3 year annual
|
|
|
|
3 year annual
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Duration of Payment
|
|
|
|
|
installment
|
|
|
|
installment
|
|
|
|
installment
|
|
|
|
installment
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
Lump Sum
|
|
|
|
|
(1) |
|
Mr. Jellisons Supplemental Executive Retirement Plan
(SERP) account balance was $498,080 as of December 31,
2006. Mr. Jellison would be entitled to additional
contributions to the plan for the years 2007 and 2008, if he
terminated his employment with the Company for cause, was
terminated by the Company or there was a |
26
|
|
|
|
|
change in control in the Company. Estimated contributions for
2007 and 2008 are based on Mr. Jellisons 2007 salary
of $383,000 multiplied by 11.7% (combined award for ESOP and
SERP) less the ESOP portion ($220,000 maximum salary multiplied
by 6%). Mr. Jellison has elected to receive his SERP
account distribution in annual installments over five years. |
|
(2) |
|
Mr. Wises Supplemental Executive Retirement Plan
(SERP) account balance was $291,276 as of December 31,
2006. Mr. Wise would be entitled to additional
contributions to the plan for the years 2007 and 2008, if he
terminated his employment with the Company for cause, was
terminated by the Company or there was a change in control in
the Company. Estimated contributions for 2007 and 2008 are based
on Mr. Wises 2007 salary of $700,000 multiplied by
11.7% (combined award for ESOP and SERP) less the ESOP portion
($220,000 maximum salary multiplied by 6%)%). Mr. Wise has
elected to receive his SERP account distribution as a lump sum
payment. |
|
(3) |
|
Mr. Clarks Supplemental Executive Retirement Plan
(SERP) account balance was $280,364 as of December 31,
2006. Mr. Clark would be entitled to additional
contributions to the plan for the years 2007 and 2008, if he
terminated his employment with the Company for cause, was
terminated by the Company or there was a change in control in
the Company. Estimated contributions for 2007 and 2008 are based
on Mr. Clarks 2007 salary of $450,000 multiplied by
11.7% (combined award for ESOP and SERP) less the ESOP portion
($220,000 maximum salary multiplied by 6%)%). Mr. Clark has
elected to receive his SERP account distribution as a lump sum
payment. |
|
(4) |
|
Mr. Addisons Supplemental Executive Retirement Plan
(SERP) account balance was $309,177 as of December 31,
2006. Mr. Addison would be entitled to additional
contributions to the plan for the years 2007 and 2008, if he
terminated his employment with the Company for cause, was
terminated by the Company or there was a change in control in
the Company. Estimated contributions for 2007 and 2008 are based
on Mr. Addisons 2007 salary of $331,000 multiplied by
11.7% (combined award for ESOP and SERP) less the ESOP portion
($220,000 maximum salary multiplied by 6%)%). Mr. Addison
has elected to receive his SERP account distribution in annual
installments over three years. |
Employment
Agreements
The Company is party to employment agreements with all of the
named executive officers. Each of these employment agreements
provides that, upon termination of such individuals
employment with the Company as a result of the employees
death, the Company is obligated to pay the employees
estate the then current base compensation of the employee for a
period of one year following the date of the employees
death, together with the employees pro rata share of any
incentive or bonus payments for the period prior to the
employees death in the year of such death. Each of the
employment agreements also provides that, in the event that the
employees employment is terminated by the Company without
cause (as defined in the employment agreements), or
by the employee with good reason (as described in
the employment agreements), (i) the Company will be
obligated to pay the employee for a period of two years
subsequent to termination of employment all compensation at the
rate paid and in the term paid to the employee during the prior
12 month period, and (ii) the employee will be
entitled to receive the benefits that would have been accrued by
him during the two year period following termination of
employment under employee benefit plans, programs or other
arrangements of the Company or any of its affiliates in which
the employee participated before the termination of his
employment. In the event that such termination of employment is
made by the Company without cause or by the employee with good
reason after a change in control (as defined in the
employment agreements), the employee may require the Company to
pay to the employee, within five days after the employees
request for such payment, the present value of the amounts that
would have been payable to him under the employment agreement
during the two year period following such termination of
employment.
The Company has also entered into employment agreements with
certain other members of senior management having terms
substantially similar to those described above.
Potential
Payments Upon Termination or Change in Control
The tables below represent the amount of compensation to each of
the named executive officers of the Company in the event of
termination from the Company under different circumstances. The
amount due to each officer upon retirement, voluntary
termination, termination by the employee with cause, termination
by the
27
company, termination following a change in control and in the
event of the death of the named executive is provided. The
amounts assume that the date of termination was
December 31, 2006 and include actual amounts earned through
that time and estimates of amounts which would be paid. The
stock price of DENTSPLY International was assumed to remain at
$29.85 per share, the closing price on December 31, 2006.
Present value calculations assumed a rate of 2.04%, the U.S
Government treasury and constant maturities inflation indexed
twenty year rate at December 31, 2006. Actual amounts to be
paid may differ and can only be determined at the time of the
executives terminations from the Company.
Payments
Made Upon Termination
The named executive officer would be entitled to receive amounts
earned during his employment, regardless of the reason for his
separation from the Company. Those amounts include:
(1) pro rata share of non-equity incentive compensation,
would be paid in February of the year following the year in
which earned;
(2) vested stock options could be exercised within
90 days of termination:
(3) lump sum distributions would be made for amounts
accrued and vested through the Companys Employee Stock
Ownership and 401(k) Plans
(4) distributions would be made based upon prior election
for amounts accrued and vested through the Companys
Supplemental Executive Retirement Plan; and
(5) lump sum distributions would be made for unused
vacation pay.
Payments
Made Upon Retirement
In addition to the items listed above, the named executive
officer would be entitled to the following :
(1) all outstanding stock options would vest as of the date
of a qualified retirement and expire the earlier of 5 years
from that date or the original expiration date;
Payments
Made Upon Termination For Cause by the Executive, or Termination
by the Company Without Cause
If a named officer separates from the Company with cause, or if
the Company terminates the executive without cause, the named
executive officer would be entitled to the following for a
period of two years from the date of notice of termination:
(1) full rate of salary immediately preceding the date of
notice of termination to be paid bi-weekly;
(2) non-equity incentive compensation based on the rate of
salary immediately preceding the date of notice of termination,
paid in February in the year following the year in which earned;
(3) Messrs. Addison and Jellison would continue to
receive equity incentive grants at the level comparable to their
positions prior to their termination. All outstanding stock
options would vest in accordance with the terms of the plan and
could be exercised up to 90 days after the second
anniversary of the date of notice of termination;
(4) annual contributions would be made to the Employee
Stock Ownership and 401(k) Plans. Lump sum distributions would
occur following the second anniversary of the date of notice of
termination;
(5) annual contributions would be made to the Supplemental
Executive Retirement Plan and distribution would be made based
on prior election; and
(6) health, accidental death and dismemberment and life
insurance coverages.
28
Payments
Made Upon Termination Due to a Change in Control of the
Company
If a named officer separates from the Company due to a change in
control of the Company, he would be entitled to the same
payments as if he had separated with cause, or if the Company
terminated the executive, except that there would be lump sum
payments for the present values of the amounts due.
Payments
Due Upon Death
If a named officer separates from the Company due to death, the
named executive officers beneficiaries would be entitled
to the following for a period of one year from the date of death:
(1) lump sum payment of a full years salary at the
rate immediately preceding the date of death;
(2) non-equity incentive compensation based on the rate of
salary immediately preceding the date of death, paid in February
of the year following the year in which earned:
(3) all outstanding stock options would vest as of the date
of death and could be exercised within 1 year;
(4) contributions would be made to the Employee Stock
Ownership, 401(k) and Supplemental Executive Retirement Plans
for the year of the death and lump sum distributions would be
made to the beneficiaries; and
(5) health, accidental death and dismemberment and life
insurance coverages for other insureds.
Gerald K.
Kunkle
Effective December 31, 2006, Mr. Kunkle retired as
Chairman of the Board and Chief Executive Officer of the
Company. Upon retiring, Mr. Kunkle received his share of
the non-equity incentive plan compensation in the amount of
$748,800, which was paid in 2007. Effective March 30, 2007
Mr. Kunkle has exercised 132,200 shares of stock worth
$1,404,776. The value of his remaining options, assuming the
market price remains constant from year-end at $29.85, is
$1,307,291. Mr. Kunkles ESOP and Company contributed
401(k) account balances were $388,289 and $6,600 respectively at
December 31, 2006. As of December 31, 2006
Mr. Kunkles SERP balance was valued at $1,211,146, of
which he has received a distribution of $881,739. The balance
will be distributed after July 5, 2007. The Company entered
into a consulting agreement with Mr. Kunkle upon his
retirement under which he will provide consulting to the
executive management of the Company through June 2007 and will
be paid a total of $400,000 in equal monthly payments.
William
R. Jellison
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
by Employee
|
|
|
by Employee
|
|
|
Termination
|
|
|
After Change
|
|
|
|
|
|
|
Retirement
|
|
|
Not For Cause
|
|
|
with Cause
|
|
|
by Company
|
|
|
in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
0
|
|
|
|
0
|
|
|
|
766,000
|
|
|
|
766,000
|
|
|
|
268,019
|
|
|
|
383,000
|
|
Non Equity Incentive Compensation
Plan
|
|
|
0
|
|
|
|
0
|
|
|
|
421,300
|
|
|
|
421,300
|
|
|
|
404,623
|
|
|
|
210,650
|
|
Stock Options
|
|
|
5,599,774
|
|
|
|
5,599,774
|
|
|
|
5,599,774
|
|
|
|
5,599,774
|
|
|
|
5,599,774
|
|
|
|
5,599,774
|
|
Employee Stock Ownership Plan
|
|
|
297,925
|
|
|
|
297,925
|
|
|
|
311,125
|
|
|
|
311,125
|
|
|
|
311,125
|
|
|
|
297,925
|
|
401(k)
|
|
|
6,600
|
|
|
|
6,600
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
6,600
|
|
Supplemental Executive Retirement
Plan
|
|
|
498,080
|
|
|
|
498,080
|
|
|
|
610,594
|
|
|
|
610,594
|
|
|
|
610,594
|
|
|
|
498,080
|
|
Medical, Dental, Vision and
Personal Accident Insurances
|
|
|
0
|
|
|
|
0
|
|
|
|
23,813
|
|
|
|
23,813
|
|
|
|
14,666
|
|
|
|
0
|
|
Long Term Disability Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
880
|
|
|
|
880
|
|
|
|
542
|
|
|
|
0
|
|
Basic Life and Accidental Death
and Dismemberment Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
850
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
6,402,379
|
|
|
|
6,402,379
|
|
|
|
7,754,666
|
|
|
|
7,754,666
|
|
|
|
7,229,993
|
|
|
|
6,996,029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29
Bret W.
Wise
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by Employee
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
Not For
|
|
|
by Employee
|
|
|
Termination
|
|
|
After Change
|
|
|
|
|
|
|
Retirement
|
|
|
Cause
|
|
|
with Cause
|
|
|
by Company
|
|
|
in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
0
|
|
|
|
0
|
|
|
|
1,400,000
|
|
|
|
1,400,000
|
|
|
|
489,852
|
|
|
|
700,000
|
|
Non Equity Incentive Compensation
Plan
|
|
|
0
|
|
|
|
0
|
|
|
|
1,400,000
|
|
|
|
1,400,000
|
|
|
|
1,344,582
|
|
|
|
700,000
|
|
Stock Options
|
|
|
2,226,438
|
|
|
|
2,226,438
|
|
|
|
2,226,438
|
|
|
|
2,226,438
|
|
|
|
2,226,438
|
|
|
|
2,226,438
|
|
Employee Stock Ownership Plan
|
|
|
71,371
|
|
|
|
71,371
|
|
|
|
84,571
|
|
|
|
84,571
|
|
|
|
84,571
|
|
|
|
71,371
|
|
401(k)
|
|
|
6,600
|
|
|
|
6,600
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
6,600
|
|
Supplemental Executive Retirement
Plan
|
|
|
291,276
|
|
|
|
291,276
|
|
|
|
592,476
|
|
|
|
592,476
|
|
|
|
592,476
|
|
|
|
291,276
|
|
Medical, Dental, Vision and
Personal Accident Insurances
|
|
|
0
|
|
|
|
0
|
|
|
|
22,776
|
|
|
|
22,776
|
|
|
|
14,028
|
|
|
|
0
|
|
Long Term Disability Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
880
|
|
|
|
880
|
|
|
|
542
|
|
|
|
0
|
|
Basic Life and Accidental Death
and Dismemberment Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
850
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,595,685
|
|
|
|
2,595,685
|
|
|
|
5,748,321
|
|
|
|
5,748,321
|
|
|
|
4,773,138
|
|
|
|
3,995,685
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Christopher
T. Clark
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
by Employee
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
Not For
|
|
|
by Employee
|
|
|
Termination
|
|
|
After Change
|
|
|
|
|
|
|
Retirement
|
|
|
Cause
|
|
|
with Cause
|
|
|
by Company
|
|
|
in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
0
|
|
|
|
0
|
|
|
|
900,000
|
|
|
|
900,000
|
|
|
|
314,905
|
|
|
|
450,000
|
|
Non Equity Incentive Compensation
Plan
|
|
|
0
|
|
|
|
0
|
|
|
|
675,000
|
|
|
|
675,000
|
|
|
|
648,280
|
|
|
|
337,500
|
|
Stock Options
|
|
|
2,634,043
|
|
|
|
2,634,043
|
|
|
|
2,634,043
|
|
|
|
2,634,043
|
|
|
|
2,634,043
|
|
|
|
2,634,043
|
|
Employee Stock Ownership Plan
|
|
|
828,025
|
|
|
|
828,025
|
|
|
|
841,225
|
|
|
|
841,225
|
|
|
|
841,225
|
|
|
|
828,025
|
|
401(k)
|
|
|
6,600
|
|
|
|
6,600
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
6,600
|
|
Supplemental Executive Retirement
Plan
|
|
|
280,364
|
|
|
|
280,364
|
|
|
|
438,239
|
|
|
|
438,239
|
|
|
|
438,239
|
|
|
|
280,364
|
|
Medical, Dental, Vision and
Personal Accident Insurances
|
|
|
0
|
|
|
|
0
|
|
|
|
22,776
|
|
|
|
22,776
|
|
|
|
14,028
|
|
|
|
0
|
|
Long Term Disability Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
880
|
|
|
|
880
|
|
|
|
542
|
|
|
|
0
|
|
Basic Life and Accidental Death
and Dismemberment Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
850
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
3,749,033
|
|
|
|
3,749,033
|
|
|
|
5,533,344
|
|
|
|
5,533,344
|
|
|
|
4,911,913
|
|
|
|
4,536,533
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30
Brian M.
Addison
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Termination
|
|
|
Termination
|
|
|
|
|
|
Termination
|
|
|
|
|
|
|
|
|
|
by Employee
|
|
|
by Employee
|
|
|
Termination
|
|
|
After Change
|
|
|
|
|
|
|
Retirement
|
|
|
Not For Cause
|
|
|
with Cause
|
|
|
by Company
|
|
|
in Control
|
|
|
Death
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Salary
|
|
|
0
|
|
|
|
0
|
|
|
|
662,000
|
|
|
|
662,000
|
|
|
|
231,630
|
|
|
|
331,000
|
|
Non Equity Incentive Compensation
Plan
|
|
|
0
|
|
|
|
0
|
|
|
|
331,000
|
|
|
|
331,000
|
|
|
|
317,897
|
|
|
|
165,500
|
|
Stock Options
|
|
|
3,883,370
|
|
|
|
3,883,370
|
|
|
|
3,883,370
|
|
|
|
3,883,370
|
|
|
|
3,883,370
|
|
|
|
3,883,370
|
|
Employee Stock Ownership Plan
|
|
|
496,951
|
|
|
|
496,951
|
|
|
|
510,151
|
|
|
|
510,151
|
|
|
|
510,151
|
|
|
|
496,951
|
|
401(k)
|
|
|
6,600
|
|
|
|
6,600
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
19,800
|
|
|
|
6,600
|
|
Supplemental Executive Retirement
Plan
|
|
|
309,177
|
|
|
|
309,177
|
|
|
|
398,958
|
|
|
|
398,958
|
|
|
|
398,958
|
|
|
|
309,177
|
|
Medical, Dental, Vision and
Personal Accident Insurances
|
|
|
0
|
|
|
|
0
|
|
|
|
23,499
|
|
|
|
23,499
|
|
|
|
14,473
|
|
|
|
0
|
|
Long Term Disability Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
880
|
|
|
|
880
|
|
|
|
542
|
|
|
|
0
|
|
Basic Life and Accidental Death
and Dismemberment Insurance
|
|
|
0
|
|
|
|
0
|
|
|
|
1,372
|
|
|
|
1,372
|
|
|
|
845
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
4,696,098
|
|
|
|
4,696,098
|
|
|
|
5,831,030
|
|
|
|
5,831,030
|
|
|
|
5,377,666
|
|
|
|
5,192,598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation
of Directors
Members of the Board of Directors who are not employees of the
Company (Outside Directors) received an annual fee
in 2006 of $40,000 ($45,000 for Outside Directors who are
chairpersons of the Human Resources and Governance Committees,
$50,000 for the chairperson of the Audit and Finance Committee
and $50,000 for the Lead Director, but Directors may not receive
additional compensation for chairing more than one committee or
acting as the Lead Director at any time) and an additional fee
of $1,500 for each Board and committee meeting attended and
$1,000 for each Board and committee meeting attended via
teleconferencing in 2006. In 2007, these fees remain $40,000,
$45,000, $50,000 and $50,000, respectively. Annual fees are paid
quarterly. Each Outside Director, at the time of such Outside
Directors appointment or election to the Board, received a
non-discretionary grant of options to purchase
20,000 shares of Common Stock. Each Outside Director will
receive an additional grant of options or equity incentives as
fixed from time to time by the Board. There were no option
grants in 2006. Directors are reimbursed for travel and other
expenses relating to attendance at Board and Committee meetings.
Effective January 1, 1997, the Company established a
Directors Deferred Compensation Plan (the Deferred
Plan). The Deferred Plan permits Outside Directors to
elect to defer receipt of directors fees or other
compensation for their services as directors. Outside Directors
can elect to have their deferred payments administered as a cash
with interest account or a stock unit account. Distributions to
a Director under the Deferred Plan will not be made to any
Outside Director until the Outside Director ceases to be a Board
member.
31
The following table shows the compensation paid to the
Companys non-employee directors for the year ended
December 31, 2006.
2006 Directors
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
Fees Earned
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
or Paid
|
|
|
|
|
|
|
|
|
Incentive Plan
|
|
|
Compensation
|
|
|
All Other
|
|
|
|
|
Name
|
|
in Cash
|
|
|
Stock Awards
|
|
|
Option Awards
|
|
|
Compensation
|
|
|
Earnings
|
|
|
Compensation
|
|
|
Total
|
|
(1)
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
Michael C. Alfano (2)
|
|
|
56,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
56,000
|
|
Eric K. Brandt (3)
|
|
|
55,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
55,500
|
|
Paula H. Cholmondeley (4)
|
|
|
70,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,500
|
|
Michael J. Coleman (5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53,500
|
|
|
|
53,500
|
|
Wendy L. Dixon (6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54,000
|
|
|
|
54,000
|
|
William F. Hecht (7)
|
|
|
|
|
|
|
61,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
61,250
|
|
Leslie A. Jones (8)
|
|
|
|
|
|
|
64,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
64,250
|
|
Francis J. Lunger (9)
|
|
|
|
|
|
|
60,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,500
|
|
John C. Miles II (10)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
51,500
|
|
|
|
51,500
|
|
W. Keith Smith (11)
|
|
|
|
|
|
|
60,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,500
|
|
|
|
|
(1) |
|
Mr. Kunkle is not shown in this table since he was an
employee of the Company as of December 31, 2006. His
compensation is shown in the Summary Compensation Table. |
|
(2) |
|
Dr. Alfano elected to receive his compensation in the form
of cash. Compensation to Dr. Alfano consisted of fees of
$16,000 for attending Board and committee meetings and the
Annual fee of $40,000. |
|
(3) |
|
Mr. Brandt elected to receive his compensation in the form
of cash. Compensation to Mr. Brandt consisted of fees of
$15,500 for attending Board and committee meetings and the
Annual fee of $40,000. |
|
(4) |
|
For 2006, Ms. Cholmondeley elected to receive her
compensation in the form of cash. Compensation to
Ms. Cholmondeley consisted of fees of $20,500 for attending
Board and committee meetings and the Annual fee of $50,000 for
chairing the Audit and Finance Committee. |
|
(5) |
|
For 2006, Mr. Coleman elected to receive his compensation
in the form of savings account with interest. His compensation
consisted of fees of $13,500 for attending Board and committee
meetings and the Annual fee of $40,000. |
|
(6) |
|
For 2006, Dr. Dixon elected to receive her compensation in
the form of savings account with interest. Her compensation
consisted of fees of $14,000 for attending Board and committee
meetings and the Annual fee of $40,000. |
|
(7) |
|
For 2006, Mr. Hecht elected to receive his compensation in
the form of the Companys stock units with dividends.
Compensation to Mr. Hecht consisted of fees of $15,000 for
attending Board and committee meetings and the Annual fee of
$46,250 for chairing the Human Resources Committee for the full
year and accepting the Lead Director role commencing 2007. |
|
(8) |
|
For 2006, Mr. Jones elected to receive his compensation in
the form of the Companys stock units with dividends.
Compensation to Mr. Jones consisted of fees of $15,500 for
attending Board and committee meetings and the Annual fee of
$48,750 for acting as Lead Director and accepting the Chair of
the Governance Committee effective 2007. |
|
(9) |
|
For 2006, Mr. Lunger elected to receive his compensation in
the form of the Companys stock units with dividends. His
compensation consisted of fees of $20,500 for attending Board
and committee meetings and the Annual fee of $40,000. |
|
(10) |
|
For 2006, Mr. Miles elected to receive his compensation in
the form of savings account with interest. Compensation to
Mr. Miles consisted of fees of $11,500 for attending Board
and committee meetings and the Annual fee of $40,000. |
32
|
|
|
(11) |
|
For 2006, Mr. Smith elected to receive his compensation in
the form of the Companys stock units with dividends. His
compensation consisted of fees of $20,500 for attending Board
and committee meetings and the Annual fee of $40,000. |
BOARD OF
DIRECTORS AND COMMITTEES
Board
of Directors Meetings
The Companys Board of Directors held six meetings during
2006, one of which was a telephone meeting. The Board of
Directors has determined that the following directors are
independent under the listing standards of The
NASDAQ Stock Market, Inc. (the Listing Standards):
Michael C. Alfano, Eric K. Brandt, Paula H. Cholmondeley,
Michael J. Coleman, Wendy L. Dixon, William F. Hecht, Leslie A.
Jones, Francis J. Lunger, John C. Miles, II and W. Keith
Smith. In determining the independence of Dr. Alfano, the
Board considered the fact that Dr. Alfano is the Executive
Vice President of New York University and from time to time the
Company sells products to the New York University College
of Dentistry. The Board determined that Dr. Alfano has no
personal interest or involvement in such transactions and that
such transactions are conducted by the relevant businesspeople
on an arms length basis with the College of Dentistry. Gerald K.
Kunkle, Jr. retired from the Board December 31, 2006.
Bret W. Wise became a member of the Board on July 24, 2006.
The Board has an Executive Committee, an Audit and Finance
Committee (Audit Committee), a Corporate Governance
and Nominating Committee (Governance Committee) and
a Human Resources Committee. No directors attended fewer than
75% of the total number of meetings of the Board and the
meetings of any committee of the Board on which a director
served during the year ended December 31, 2006, other than
Eric K. Brandt, who attended 70%. The current composition and
activities of the Committees are described below.
Executive
Committee
The Executive Committee acts for the Board and provides guidance
to the executive officers of the Company between meetings of the
Board. The members of the Executive Committee in 2006 were
Messrs. Jones, Miles and Kunkle. Mr. Kunkle served as
Chairman of the committee until his retirement from the Board in
December 2006. The Executive Committee held three meetings
during 2006, all of which were telephone meetings. Effective
February 14, 2007, the Executive Committee members are
Messrs. Wise, Jones, Miles and Hecht.
Audit
Committee
The Audit Committee is responsible for selecting and retaining
the independent registered public accounting firm, setting the
independent registered public accounting firms
compensation, pre-approving all auditing and permitted non-audit
services by the independent registered public accounting firm,
reviewing with the independent registered public accounting firm
the scope and results of the audit, reviewing the adequacy and
effectiveness of the Companys system of internal control
and performing the other duties set forth in the Audit and
Finance Committee Charter (a copy of the Audit and Finance
Committee Charter is attached to this Proxy Statement as
Appendix B).
The members of the Audit Committee in 2006 were
Ms. Cholmondeley, (Chairwoman) and Messrs. Brandt and
Lunger, all of whom are independent as defined in the Listing
Standards. The Board has determined that Ms. Cholmondeley
and Mr. Brandt are Audit Committee Financial Experts under
the rules and regulations of the Securities and Exchange
Commission. The Audit Committee held ten meetings during 2006,
six of which were telephone meetings. The Audit Committee
members remain the same in 2007.
Governance
Committee
The Governance Committee is responsible for identifying and
recommending individuals as nominees to serve on the Board,
reviewing and recommending Board policies and governance
practices and appraising the performance of the Board and
performing the other duties set forth in the Governance
Committee Charter (a copy of the Governance Committee Charter is
attached to this Proxy Statement as Appendix C). The
members of the Committee in 2006 were Messrs. Jones
(Chairman) and Smith, Drs. Dixon and Alfano, all of whom
are independent as defined in the Listing Standards. Effective
February 14, 2007 the members of the Governance Committee
are Messrs. Smith (Chairman), Jones, and Miles and
Dr. Dixon.
33
It is the policy of the Governance Committee to consider any
candidates for nomination to the Board who are recommended and
submitted by security holders in accordance with the
Companys by-laws (see Stockholder Proposals for Proxy
Statement and Nominations in this Proxy Statement). No such
candidates were submitted to the Company for consideration. The
Governance Committees policy is to evaluate any proposed
candidates under the criteria utilized by the Governance
Committee to evaluate all potential nominees, including, at a
minimum, the following attributes:
|
|
|
|
|
the proven ability and experience to bring informed, thoughtful
and well-considered opinions to corporate management and the
Board;
|
|
|
|
the competence, maturity and integrity to monitor and evaluate
the Companys management, performance and policies;
|
|
|
|
the willingness and ability to devote the necessary time and
effort required for service on the Board;
|
|
|
|
the capacity to provide additional strength, diversity of view
and new perceptions to the Board and its activities;
|
|
|
|
the necessary measure of communication skills and
self-confidence to ensure ease of participation in Board
discussion; and
|
|
|
|
who hold or have held a senior position with a significant
business corporation or a position of senior leadership in an
educational, medical, religious, or other non-profit institution
or foundation of significance.
|
When the Governance Committee engages in a process to identify
director candidates, other than directors standing for
re-election, the Governance Committee polls the existing
directors for recommendations and sometimes utilizes the service
of a search firm to identify potential candidates. All potential
candidates are screened relative to their qualifications and go
through an interview process with the Governance Committee and,
if desired, by other members of the Board. When the Governance
Committee uses a search firm, a fee is paid for such services.
The Corporate Governance Committee held four meetings during
2006, one of which was a telephone meeting.
Human
Resources Committee
The Human Resources Committee is responsible for evaluating and
administering compensation levels for all senior officers of the
Company, reviewing and evaluating employee compensation
generally, and employee benefit plans and other activities as
set forth in the Human Resources Committee Charter (a copy of
the Human Resources Committee Charter is attached to this Proxy
Statement as Appendix D). Its members in 2006 were
Messrs. Hecht (Chairman), Coleman and Smith and
Dr. Alfano, all of whom are independent as defined in the
Listing Standards. The Human Resources Committee met five times
during 2006, two of which were telephone meetings. Effective
February 14, 2007, the members of the Human Resources
Committee are Messrs. Hecht and Coleman and Dr. Alfano.
Human
Resources Committee Interlocks and Insider
Participation
None of the current members of the Human Resources Committee has
ever been an officer or employee of DENTSPLY. None of our
executive officers served as a member of the board of directors
or compensation committee of any entity that has one or more
executive officers serving on our Board of Directors or Human
Resources Committee.
Attendance
at Annual Meetings
The Company has no policy regarding the attendance of Board
members at the Companys Annual Stockholders Meeting. In
2006, all Board members attended the Annual Meeting of
Stockholders.
Related
Person Transactions
No related person transactions were noted for the year ended
December 31, 2006.
The Company has a written policy and procedures with respect to
the review and approval of Related Person Transactions. The
Corporate Governance and Nominating Committee (the
Committee) reviews the material facts of all Related
Person Transactions that require the Committees approval
and either approves or disapproves of the
34
entry into the Transaction, subject to certain identified
exceptions described below. In determining whether to approve or
ratify a Related Person Transaction, the Committee takes into
account, among other factors it deems appropriate, whether the
Transaction is on terms no less favorable than terms generally
available to an unaffiliated third-party under the same or
similar circumstances and the extent of the Related
Persons interest in the Transaction. The Chair of the
Committee is delegated the authority by the Board to approve
Related Party Transactions that, because of timing or
scheduling, are not feasible to be approved by the full
Committee.
The policy applies to any transaction, arrangement or
relationship in which the Company (including any of its
subsidiaries) will be a participant and in which any Related
Person (as defined by SEC Rules) will have a direct or indirect
material interest, and the amount involved exceeds $120,000.
The Committee has pre-approved, under the policy, the following
Related Person Transactions without regard to the amount
involved:
1. any Transaction involving the compensation, employment
and/or
benefits of an executive officer of the Company if the
compensation arising from the Transaction is required to be
reported in the Companys proxy statement;
2. any Transaction involving the compensation, employment
and/or
benefits of an executive officer of the Company that is not a
named executive officer (as that term is defined in
Item 402(a)(3) of
Regulation S-K)
if (a) the executive officer is not an immediate family
member of another executive officer or director of the Company,
(b) the compensation arising from the Transaction would
have been reported under Item 402 as compensation earned
for services to the Company if the executive officer was a
named executive officer, and (c) such
compensation had been approved, or recommended to the Board of
Directors of the Company for approval, by the Human Resources
Committee of the Board of Directors;
3. any Transaction involving the compensation, services
and/or
benefits of a director if the compensation arising from the
Transaction is required to be reported in the Companys
proxy statement;
4. any Transaction where the Related Persons interest
arises solely from the ownership of the Companys common
stock and all holders of the Companys common stock
received the same benefit on a pro rata basis;
5. any Transaction with a Related Party involving the
rendering of services as a common or contract carrier, or public
utility, at rates or charges fixed in conformity with law or
governmental authority;
6. any Transaction with a Related Party involving services
as a bank depositary of funds, transfer agent, registrar,
trustee under a trust indenture, or similar services;
7. any Transaction in which the interest of the Related
Person arises solely from such persons position as a
director of another firm, corporation or other entity that is a
party to the Transaction.
Except to the extent pre-approved, as noted above, Related
Person Transactions are subject to the following procedures. The
Related Person notifies the General Counsel of the Company of
any proposed Transaction, including: the Related Persons
relationship to the Company and interest in the proposed
Transaction; the material terms of the proposed Transaction; the
benefits to the Company of the proposed Transaction; and the
availability from alternative sources of the products or
services that are the subject of the proposed Transaction.
The proposed Related Person Transaction is submitted to the
Committee for consideration at the next Committee meeting or, if
the legal department, after consultation with the Chief
Executive Officer or the Chief Financial Officer, determines
that the Company should not wait until the next Committee
meeting, to the Chair of the Committee acting pursuant to
authority delegated by the Board. Any Transactions approved
pursuant to delegated authority by the Chair of the committee,
is reported to the Committee at the next Committee meeting.
To the extent the Company becomes aware of a Related Person
Transaction that was not previously approved under this policy,
it shall be promptly reviewed as described above and be
ratified, amended or terminated, as determined appropriate by
the Committee.
35
AUDIT AND
FINANCE COMMITTEE DISCLOSURE
The Audit and Finance Committee (Audit Committee)
was comprised of three directors in 2006, all of whom are
independent as defined by the Listing Standards. In addition,
Mr. Brandt and Ms. Cholmondeley have been designated
by the Board as audit committee financial experts
under applicable rules and regulations of the Securities and
Exchange Commission. The Audit Committee operates under a
written charter adopted by the Board of Directors. This charter
is reviewed at least annually by the Committee and the Board and
amended as determined appropriate (a copy of this charter is
attached to this Proxy Statement as Appendix B).
The Audit Committee reviews the Companys financial
reporting process on behalf of the Board. In addition, the
Committee approves and retains the Companys independent
registered public accounting firm.
Management is responsible for the Companys internal
controls, including internal control over financial reporting,
and the financial reporting process. The independent registered
public accounting firm is responsible for performing an audit of
the Companys financial statements in accordance with
generally accepted auditing standards and an audit of the
Companys internal control over financial reporting; and to
issue a report thereon. The Committees responsibility is
to oversee these processes.
In this context, the Committee has met and held discussions with
management and PwC, the Companys independent registered
public accounting firm. Management represented to the Committee
that the Companys financial statements were prepared in
accordance with generally accepted accounting principles, and
the Committee has reviewed and discussed the audited financial
statements with management and PwC. The Committee discussed with
PwC the matters required to be discussed by Statement on
Auditing Standards No. 61 (Communication with Audit
Committees).
In addition, the Committee has discussed with PwC the
firms independence from the Company and its management and
has received the written disclosures and the letter from PwC
required by Independence Standards Board Standard No. 1
(Independence Discussions with Audit Committees), as it has been
modified or supplemented.
The Committee discussed with PwC the overall scope and plans for
their audits. The Committee meets with PwC, with and without
management present, to discuss the results of their
examinations, the evaluations of the Companys internal
controls, and the overall quality of the Companys
financial reporting.
Based upon the Committees discussions with management and
PwC and the Committees review of the representations of
management and the report of PwC to the Committee, the Committee
recommended that the Board include the audited financial
statements in the Companys Annual Report on
Form 10-K
for the year ended December 31, 2006 filed with the
Securities and Exchange Commission.
AUDIT AND
FINANCE COMMITTEE
|
|
|
Paula
H. Cholmondeley
|
Eric
K. Brandt
|
Francis
J. Lunger
|
PROXY
DELIVERY STATEMENT
As permitted by law, one copy of the Companys Proxy
Statement and Annual Report is delivered to stockholders
residing at the same address, unless such stockholders have
notified the Company of their desire to receive multiple copies
of the Proxy Statement and Annual Report. We believe this
Householding approach provides greater convenience
for our stockholders, as well as cost savings for us by reducing
the number of duplicate documents that are sent to the same
address.
The Company will promptly deliver, upon oral or written request,
a separate copy of the Proxy Statement and Annual Report to any
stockholders residing at an address to which only one copy was
delivered. Requests for additional copies should be directed to
ADP, either by calling toll-free
(800) 542-1061,
or by writing to ADP, Householding Department, 51 Mercedes Way,
Edgewood, New York, 11717.
36
Stockholders residing at the same address and currently
receiving multiple copies of the Proxy Statement may also
contact ADP, as noted above, to request that only a single copy
of such document be mailed in the future.
We strongly encourage your participation in the Householding
program, and believe that it will benefit both you and the
Company. Not only will it reduce the volume of duplicate
information that you receive in your household, but it will also
reduce our printing and mailing costs.
STOCKHOLDER
COMMUNICATIONS STATEMENT
The Board of Directors has no specific formal process for
security holders to send communications to the Board. The Board
does not believe a specific process is necessary in the event
security holders wish to direct communications to a Board
member. All Board members, including their Committee
assignments, are identified each year in the Companys
Proxy Statement. Communications which are intended for Board
members can be sent to the Company for delivery to individual
Board members. All mail received will be opened and screened for
security purposes and mail determined to be appropriate and
within the purview of the Board will be delivered to the
respective Board member to which the communication is addressed.
Mail addressed to Outside Directors or
Non-Management Directors will be forwarded or
delivered to the Chairman of the Corporate Governance and
Nominating Committee. Mail addressed to the Board of
Directors will be forwarded or delivered to the Chairman
of the Board.
STOCKHOLDER
PROPOSALS FOR PROXY STATEMENT AND NOMINATIONS
Stockholder proposals that are intended to be presented at the
Companys Annual Meeting of Stockholders to be held in 2008
must be received by the Company no later than December 12,
2007, and must otherwise comply with
Rule 14a-8
under the Securities Exchange Act, as amended, in order to be
included in the proxy statement and proxy relating to that
meeting.
The Companys by-laws provide that advance notice of
stockholder-proposed business to be brought before an Annual
Meeting of Stockholders must be given to the Secretary of the
Company not less than 60 days in advance of the date of the
mailing of materials regarding the prior years Annual
Meeting, which mailing date is identified on the Chairmans
letter at the front of the proxy statement. To propose business
for an Annual Meeting, a stockholder must specify in writing the
business desired to be brought before the Annual Meeting and the
reasons for conducting such business at the Annual Meeting, the
proposing stockholders name and address, the class and
number of shares beneficially owned by the stockholder, and any
material interest of the stockholder in such business. In order
to be brought before the 2008 Annual Meeting, stockholders must
notify the Company in writing, in accordance with the procedures
set forth above, of any stockholder-proposed business no later
than February 9, 2008.
The Companys by-laws also provide that a stockholder may
request that persons be nominated for election as directors by
submitting such request, together with the written consent of
the persons proposed to be nominated, to the Secretary of the
Company not less than 60 days prior to the date of the
Annual Meeting. To be in proper form, the nominating stockholder
must set forth in writing, as to each proposed nominee, the
nominees age, business address, residence address,
principal occupation or employment, number of shares of Common
Stock of the Company beneficially owned by such person and such
other information related to such person as is required to be
disclosed by applicable law, and, as to the stockholder
submitting the request, such stockholders name and address
as they appear on the Companys books and the number of
shares of Common Stock of the Company owned beneficially by such
person.
FORM 10-K
STOCKHOLDERS MAY OBTAIN AN ADDITIONAL COPY (WITHOUT EXHIBITS) OF
THE COMPANYS ANNUAL REPORT ON
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 2006 AS FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION WITHOUT CHARGE BY WRITING TO:
INVESTOR RELATIONS DEPARTMENT, DENTSPLY INTERNATIONAL INC.,
SUSQUEHANNA COMMERCE CENTER, 221 WEST PHILADELPHIA STREET, YORK,
PENNSYLVANIA
17405-0872.
37
CORPORATE
GOVERNANCE GUIDELINES
During 2006, the Board of Directors made some revisions to its
Corporate Governance Guidelines and Policies. A copy of such
Guidelines and Policies are set forth as Appendix E to the
Proxy Statement.
OTHER
MATTERS
The Board of Directors knows of no matters which are to be
brought before the Annual Meeting other than those set forth in
this Proxy Statement. If any other matters properly come before
the Annual Meeting, the person named in the enclosed proxy card,
or his duly appointed substitute acting at the Annual Meeting,
will be authorized to vote or otherwise act thereon in
accordance with his judgment on such matters.
38
APPENDIX A
FIRST
AMENDMENT
TO
DENTSPLY INTERNATIONAL INC.
2002 AMENDED AND RESTATED EQUITY INCENTIVE PLAN
WHEREAS, DENTSPLY International Inc. (the
Company) previously adopted and presently
maintains the DENTSPLY International Inc. 2002 Amended and
Restated Equity Incentive Plan, as most recently amended and
restated as of March 22, 2005 (the Plan);
WHEREAS, pursuant to Section 16 of the Plan, the Plan may
be amended by action of the Companys Board of Directors
(the Board), subject to shareholder approval
where required by tax or other laws and regulations;
WHEREAS, the Board has determined that it is in the best
interests of the Company to amend certain provisions of the Plan
as set forth herein to (i) eliminate automatic annual stock
option grants to Outside Directors and instead subject such
grants to the general discretionary authority of the Human
Resources Committee to make Awards under the Plan, (ii) add
provisions establishing objective performance criteria for
certain Restricted Stock and Restricted Stock Unit awards, in
order to satisfy applicable requirements under
Section 162(m) of the Internal Revenue Code of 1986, as
amended, and; (iii) clarify the method by which the
fair market value of Company common stock is
determined for Plan purposes, and
WHEREAS, the amendment referenced in subsection (i) of
the above paragraph was adopted by the Board of Directors of the
Company on March 28, 2007 and the amendment referenced in
subsection (ii) of the above paragraph was adopted by
the Board of Directors of the Company on February 14, 2007
and, if this Amendment is approved by the stockholders of the
Company, it will be deemed to have become effective as of
May 15, 2007;
NOW THEREFORE, the Plan is hereby amended in the following
respects:
1. Section 2 of the Plan, entitled
Eligibility, is hereby amended by deleting the first
sentence of such Section in its entirety and substituting
therefor the following:
Outside Directors shall be eligible to participate in the
Plan in the same manner as Key Employees (as defined below) and
other participants in the Plan.
2. Section 3.2 of the Plan, entitled Authority
of the Committee, is hereby amended by deleting the second
sentence of such Section in its entirety and substituting
therefor the following:
The Committee, in its sole discretion, shall determine the
Outside Directors, Key Employees, consultants and advisors to
whom, and the time or times at which, Awards will be granted,
the number of shares to be subject to each Award, the expiration
date of each Award, the time or times within which the Option
may be exercised or forfeiture restrictions lapse, the
cancellation or termination of the Award and the other terms and
conditions of the grant of the Award..
3. Section 5 of the Plan, entitled Grant of
Options to Outside Directors, is hereby deleted in its
entirety, and the following substituted therefor:
SECTION 5
[INTENTIONALLY OMITTED]
4. Section 6 of the Plan, entitled Grant of
Options to Employees, Consultants and Advisers, is hereby
amended by inserting Outside Directors, before
Employees in the title of such Section.
5. Section 6.1 of the Plan, entitled
Grants, is hereby amended by deleting the first
sentence of such Section in its entirety and substituting
therefor the following:
Subject to the terms of the Plan, the Committee may from
time to time grant Options which are ISOs to Key Employees and
Options which are NSOs to Outside Directors, Key Employees,
consultants and advisers of the Company.
A-1
6. Section 6.4 of the Plan, entitled Required
Terms and Conditions of ISOs, is hereby amended by
deleting subsection (a) of such Section in its
entirety and substituting therefor the following:
(a) Except as provided in Section 6.4(c), the
exercise price per share of each ISO shall be the Fair
Market Value of a share of Common Stock on the date such
ISO is granted. For purposes of the Plan, Fair Market
Value shall mean the closing sales price of the Common
Stock on The Nasdaq National Market, or other national
securities exchange which is the principal securities market on
which the Common Stock is traded (as reported in The Wall Street
Journal, Eastern Edition).
7. Section 6.5 of the Plan, entitled Required
Terms and Conditions of NSOs, is hereby amended by
inserting Outside Directors, before Key
Employees.
8. Section 10.1 of the Plan, entitled General
Requirements, is hereby amended by deleting the third
sentence of such Section in its entirety and substituting
therefor the following:
The Committee may establish conditions under which
restrictions on shares of Restricted Stock
and/or
Restricted Stock Units shall lapse over a period of time or
according to such other criteria (including performance-based
criteria which are intended to satisfy the qualified
performance-based compensation exception from the tax
deductibility limitations of Section 162(m) of the Code) as
the Committee deems appropriate.
9. Section 10 of the Plan, entitled Restricted
Stock and Restricted Stock Units, is hereby amended by
inserting the following new subsection:
10.6 Performance-Based Criteria
At the Committees discretion, awards of Restricted Stock
and Restricted Stock Units may be made subject to the attainment
of performance goals which are intended to satisfy the qualified
performance-based compensation exception from the tax
deductibility limitations of Section 162(m) of the Code.
The performance criteria shall consist of one or more or any
combination of the following measures: net sales (with or
without precious metal content); sales growth; operating income;
earnings before or after tax; earnings before interest and
taxes; earnings before interest, taxes, depreciation and
amortization; cash flow; gross or net margin; earnings per share
(whether on a pre-tax, after-tax, operational or other basis);
ratio of debt to debt plus equity; credit quality or debt
ratings; capital expenditures; expenses or expense levels; ratio
of operating earnings to revenues or any other operating ratios;
the extent to which business goals are met; the accomplishment
of mergers, acquisitions, dispositions, or similar extraordinary
business transactions; price of the Companys Common Stock;
market share criteria; management of costs; return on assets,
net assets, invested capital, equity, or stockholders
equity; market share; inventory levels, inventory turn or
shrinkage; regulatory compliance; total return to stockholders
(Performance Criteria). The Performance Criteria may
be applied to the performance of the Company as a whole or any
business unit of the Company and may be measured relative to a
peer group or index selected by the Committee, provided that,
the Performance Criteria shall be calculated consistently with
the Companys financial statements, under generally
accepted accounting principles, or under a methodology
established by the Committee in connection with the granting of
an Award which is consistently applied with respect to that
Award. To the extent the Committee deems appropriate,
Performance Criteria may exclude or otherwise be adjusted for
(i) extraordinary, unusual
and/or
non-recurring items of gain or loss, (ii) gains or losses
on the disposition of a business, (iii) the effect of
changes in tax
and/or
accounting regulations, laws or principles and the
interpretation thereof, or (iv) the effects of mergers,
acquisitions
and/or
dispositions. This Section 10.6 shall not limit the
discretion of the Committee to grant Awards that do not satisfy
the requirements of the qualified performance-based compensation
exception from the tax deductibility limitations of
Section 162(m) of the Code.
10. In all other respects, the Plan is hereby ratified and
affirmed, and the appropriate officers of the Company be, and
each of them hereby is, authorized and directed in the name and
on behalf of the Company to take such action and execute and
deliver such documents, with such changes or modifications, if
any, as they or any of them may approve as necessary,
appropriate or desirable in connection with implementing the
above-specified amendments, including, without limitation, for
the purpose of submitting such amendments for approval by the
Companys shareholders if and to the extent required by
Section 16 of the Plan or otherwise.
A-2
APPENDIX B
DENTSPLY
International Inc.
Audit & Finance Committee Charter
The primary function of the Audit & Finance Committee
(Committee) is to assist the Board of Directors
(Board) in fulfilling its oversight responsibilities
related to corporate accounting and financial reporting
disclosures, corporate financing activities, treasury activities
and risk management activities. It shall be the policy of the
Committee to maintain free and open communication between the
Board, the independent accountants, the internal auditors and
the management of the Company.
|
|
1.
|
Members The Committee shall be composed of
directors who are independent, as defined by the Securities and
Exchange Commission and NASDAQ, of the management of the Company
and are free of any relationship that, in the opinion of the
Board, would interfere with their exercise of independent
judgment as a committee member. Committee members shall be
nominated by the Board, and the Committee shall be composed of
not less than three independent Directors who meet the NASDAQ
requirements regarding financial knowledge, experience and
expertise.
|
|
2.
|
Meetings The Committee will meet on a regular
basis and special meetings will be called as circumstances
require. The Committee will meet privately from time to time
with representatives of the Companys independent
accountants, the internal auditor and management. Written
minutes will be kept for all meetings.
|
|
3.
|
Funding The Committee shall receive
sufficient funding to carry out its functions, including the
hiring of outside advisors as deemed appropriate by the
Committee.
|
|
|
1. |
Financial Oversight and Reporting The
Committee shall have the role and responsibility for monitoring
and overseeing the management, gathering and reporting of
financial data and information, which shall include:
|
|
|
|
|
A.
|
The appointment, compensation, retention and oversight of the
independent accountants.
|
|
|
B.
|
Review and approve the plans, scope and results for the annual
audit with the independent accountants and address any
significant financial reporting issues which arose during the
audit and their resolution.
|
|
|
C.
|
Review and approve the plans, scope, budget and results for the
internal audit function and address any significant issues
raised by the internal audit function.
|
|
|
D.
|
Review significant developments in accounting rules and
recommended changes in the Companys methods of accounting
or financial statements and application of the rules and the
Companys accounting principles to the Companys
financial reporting.
|
|
|
E.
|
Review and evaluate the adequacy of internal accounting controls
and internal control systems.
|
|
|
2. |
Finance In carrying out its Finance function,
the Committee may undertake such actions as it deems necessary
or useful and providing updates and recommendations to the Board
of Directors which may include:
|
|
|
|
|
A.
|
Capital Structure. Receiving reports from management about the
current capital structure and proposed changes to the capital
structure.
|
|
|
B.
|
Dividend Policy. Reviewing analyses from management about the
current dividend policy of the Company and provide
recommendation to the Board of Directors.
|
B-1
|
|
|
|
C.
|
Financing Activities. Reviewing analyses from management
including accounting, tax and financing activities associated
with proposed material financing transactions and provide
recommendation to the Board of Directors.
|
|
|
D.
|
Capital Expenditures. At the request of the Board, review
specific projects proposed by Management as well as perform a
post implementation review of major projects.
|
|
|
E.
|
Benefit Plan Funding Matters. Reviewing reports from management
concerning the funding requirements for the Companys
employee benefit plans.
|
|
|
F.
|
Insurance. Reviewing the Companys insurance coverage and
the related costs.
|
|
|
G.
|
Review and approve policies and procedures with respect to Debt
Management, Financial Risk Management, Credit Management and
Global Cash Investment Management.
|
|
|
H.
|
Review tax compliance programs and the tax optimization
strategies of the company.
|
|
|
I.
|
Review the financial and accounting components of any material
transactions significantly impacting the company.
|
|
|
3.
|
Information Technology Review information
technology plans with respect to corporate goals, industry
trends, and competitive advantages. Review and assess the
security of computer systems and applications and contingency
plans for computer system breakdowns, particularly with respect
to the processing of financial information.
|
|
4.
|
Complaint Handling Review and approve the
procedures established for the receipt, retention and treatment
of complaints received by the Company regarding accounting,
internal controls or auditing matters.
|
|
5.
|
Outside Advisors The Committee shall directly
engage independent advisors when deemed appropriate by the
Committee.
|
In carrying out its responsibilities, the Committee shall remain
flexible in its policies and procedures in order that it can
best react to changing conditions and environment and to assure
to the directors and shareholders that the corporate accounting,
reporting and financing practices of the Company are in
accordance with all requirements and are of the highest quality.
B-2
APPENDIX C
DENTSPLY
INTERNATIONAL INC.
Corporate Governance and Nominating Committee Charter
The primary function of the Corporate Governance and Nominating
Committee (Committee) is to assist the Board of
Directors of the Company (the Board) in the
establishment of criteria for the selection and nomination of
Board members and to establish policies and procedures for the
governance of the Company and the Board. The Committee shall
report to the Board on matters relating to the activities of the
Committee.
|
|
A.
|
Members. The Committee shall consist of
directors who are independent, as defined by NASDAQ and SEC
rules, and are free from any relationship with the Company or
management of the Company that, in the opinion of the Board as
evidenced by its election of such Committee members, would
interfere with the exercise of independent judgment as a
Committee member.
|
|
B.
|
Meetings. The Committee will meet as
often as necessary to carry out its responsibilities. Meetings
may be called by the Chairman of the Committee
and/or
management of the Company. Written minutes of each meeting shall
be duly filed in the Company records. Reports of meetings of the
Committee shall be made to the Board accompanied by any
recommendations to the Board for matters that the Committee
determines requires approval of the Board.
|
The Committee shall have the following specific responsibilities:
|
|
|
|
|
Review the qualifications of and recommend to the Board
(i) those persons to be nominated for membership on the
Board who shall be submitted to the shareholders for election at
each Annual Meeting of Shareholders, including consideration of
candidates recommended by shareholders in accordance with the
by-laws and procedures of the Company and (ii) the nominees
for directors to be elected by the Board to fill vacancies and
newly created directorships;
|
|
|
|
Establish criteria for membership on the Board of Directors and
its Committees, such as depth of experience, business interest
and experience, required expertise and qualifications for
membership on each Committee;
|
|
|
|
Aid in recruiting and attracting qualified candidates to serve
on the Board;
|
|
|
|
Consider and appraise the performance of incumbent members of
the Board in determining whether to recommend that they be
nominated for re-election;
|
|
|
|
Make recommendations to the Board concerning (i) the size
and composition of the Board and (ii) the size and
composition of each standing Committee of the Board;
|
|
|
|
Recommend appointments of directors as members of Committees of
the Board;
|
|
|
|
Periodically review and recommend Governance Guidelines and
Policies, including, but not limited to: (i) recommending
the policy governing retirement of directors from the Board,
(ii) recommending the term of office for directors and
whether or not the Board should be classified according to
terms, (iii) recommending the desirable ratio of employee
and non-employee directors, and (iv) reviewing the format
and content of Board meetings and making recommendations for the
improvement of such meetings.
|
|
|
|
Approve the acceptance of outside Board seats by Company
executives;
|
|
|
|
Review the compensation of the members of the Board for services
as a director or member of any Committee of the Board and make
recommendations to the Board concerning the fixing of such
compensation;
|
C-1
|
|
|
|
|
Evaluate Company policies relating to the recruitment of
directors, including D&O insurance and indemnification and
make recommendations to the Board, or any appropriate Board
Committee, regarding such matters; and
|
|
|
|
Review periodically, in the light of changing conditions, new
legislation, regulations and other developments, the
Companys Code of Conduct, and make recommendations to the
Board for any changes, amendments and modifications to the Code
that the Committee shall deem desirable.
|
|
|
|
Review and report to the Board annually concerning Board member
independence as defined by the NASDAQ rules.
|
|
|
|
Annually, direct the evaluation of the functioning of the Board
in accordance with procedures established by the Board and make
recommendations to the Board on implementation of changes.
|
The Committee shall directly engage independent advisors when
deemed appropriate by the Committee.
C-2
APPENDIX D
DENTSPLY
INTERNATIONAL INC.
Human Resources Committee Charter
The primary function of the Human Resources Committee is to
provide general oversight and assistance to the Board of
Directors of the Company (the Board) for the
organizational structure of the Company and the compensation and
hiring plans, policies and practices of the Company, including
specifically the compensation of the executive officers.
|
|
A.
|
Composition. The Committee shall
consist of directors who are independent, as defined by NASDAQ
and SEC rules, and are free from any relationship with the
Company or management of the Company that, in the opinion of the
Board as evidenced by its appointment of such Committee
members, would interfere with the exercise of independent
judgment as a Committee member.
|
|
B.
|
Meetings. The Committee will meet as
often as necessary to carry out its responsibilities. Meetings
may be called by the Chairman of the Committee
and/or
management of the Company. A majority of the Committee shall
constitute a quorum. Written minutes of each meeting shall be
duly filed in the Company records. Reports of meetings of the
Committee shall be made to the Board accompanied by any
recommendations to the Board for matters that the Committee
determines requires approval of the Board.
|
|
|
A. |
General. The Committees general
responsibility is to oversee the Companys employment,
hiring and compensation plans, personnel practices and policies,
and assure that the senior executives of the Company and its
wholly-owned affiliates are compensated effectively in a manner
consistent with the stated compensation strategy of the Company,
internal equity considerations, competitive practice, and the
requirements of the appropriate regulatory bodies. The Committee
shall communicate to shareholders, as deemed appropriate or as
required by the Securities and Exchange Commission or other
regulatory body, the Companys compensation policies and
practices. More specifically, the Committee shall be responsible
for the following:
|
|
|
|
|
|
Reviewing periodically the appointments, promotions and
performance of certain officers of the Company and the potential
successors of the principal executive officers of the Company,
as the Committee shall designate, and making recommendations to
the Board with respect to such matters to the extent it deems
appropriate;
|
|
|
|
Review from time to time and approve the Companys stated
compensation strategy to ensure that management is rewarded
appropriately for its contributions to Company growth and
profitability and that the executive compensation strategy
supports organization objectives and shareholder interests;
|
|
|
|
Review annually and determine the individual elements of total
compensation for the executive management of the Company and
communicate in the annual Board Compensation Committee Report to
shareholders the factors and criteria on which the executive
officers, including the Chief Executive Officers,
compensation for the last year was based;
|
|
|
|
Assure that the Companys executive incentive compensation
program(s) are administered in a manner consistent with the
Companys compensation strategy as to participation, target
annual incentive awards, corporate financial goals, and actual
awards paid to executive management;
|
|
|
|
Approve, subject to shareholders approval when appropriate, all
new equity-related incentive plans for senior management;
|
|
|
|
Recommend to the Board participants in the Companys
Supplemental Executive Retirement Plan;
|
D-1
|
|
|
|
|
Review the recruitment, hiring and promotion practices of the
Company and its subsidiaries in the light of applicable legal
requirements and corporate governance policies established by
the Board;
|
|
|
|
Receive and review annually or otherwise, as the Committee shall
deem appropriate, reports on significant matters and actions
taken in connection with the operation and administration of the
employee benefits plans of the Company and its subsidiaries;
|
|
|
|
Review with the Chief Executive Officer matters relating to
management succession;
|
|
|
|
If appropriate, hire experts in the field of executive
compensation and other matters related to the functions of the
Committee to assist the Committee with its areas of
responsibility; and
|
|
|
|
Such other duties and responsibilities as may be assigned to the
Committee, from time to time, by the Board of the Company, or as
designated in Company plan documents.
|
|
|
B.
|
Consultants. The Committee shall at all
times have the authority to retain and terminate any
compensation consultants or other advisors to assist it in any
aspect of the evaluation of executive compensation or on any
other subject relevant to the Committees responsibilities,
including the authority to approve such consultants or
advisors fees and other retention terms.
|
|
C.
|
Equity Compensation Plan. The Committee
shall administer the Equity Incentive Plans, including but not
limited to:
|
|
|
|
|
|
Consider relevant market data and Company and individual
performance relative to the types and size of awards;
|
|
|
|
Participating in the establishment of plan guidelines and
general size of overall grants;
|
|
|
|
Making grants;
|
|
|
|
Interpreting the Plans;
|
|
|
|
Determining rules and regulations relating to the Plans;
|
|
|
|
Modifying existing or canceling existing grants and substituting
new ones (with the consent of the grantees);
|
|
|
|
Approving any exceptions to receive retiree treatment; and
|
|
|
|
Authorizing foreign subsidiaries to adopt plans pursuant to the
provisions of the Plans.
|
D-2
APPENDIX E
DENTSPLY
INTERNATIONAL INC.
CORPORATE GOVERNANCE GUIDELINES/POLICIES
(Revised April 2006)
The following Corporate Governance Guidelines have been adopted
by the Board of Directors of the Corporation to assist the Board
in the exercise of its responsibilities. These Corporate
Governance Guidelines reflect the Boards commitment to
monitor the effectiveness of policy and decision making both at
the Board and management level. These Corporate Governance
Guidelines shall be reviewed by the Board, through the
Governance Committee (or successor thereof), on a periodic basis
and are subject to modification from time to time by the Board.
I. Functions/Responsibilities of the Board of
Directors
The Directors shall have the authority to manage the business
and affairs of the Corporation in accordance with the Delaware
General Corporation law and as set forth in the By-Laws.
Directors shall discharge the duties of their positions in good
faith, in a manner reasonably believed to be in the best
interests of the Corporation and with such care, including
reasonable inquiry, skill and diligence as a person of ordinary
prudence would use under similar circumstances. The
responsibility of the Board of Directors is to supervise and
direct the management of the Corporation. To that end, the Board
of Directors (references to the Board include the Committees of
the Board, as applicable) shall have the following duties:
|
|
|
|
(1)
|
Overseeing the conduct of the Corporations business to
evaluate whether the business is being properly managed;
|
|
|
(2)
|
Reviewing and, where appropriate, approving the
Corporations major financial objectives, plans and
actions, including its longer term strategic plans;
|
|
|
(3)
|
Reviewing the Corporations financial statements;
|
|
|
(4)
|
Assessing major risk factors relating to the Corporation and its
performance, and reviewing measures to address and mitigate such
risks;
|
|
|
(5)
|
The selection and appointment and regularly evaluating the
performance and approving the compensation of the Chief
Executive Officer and, with the advice of the Chief Executive
Officer, the principal senior executives; and
|
|
|
(6)
|
Planning for succession with respect to the position of Chief
Executive Officer and monitoring managements succession
planning for other key executives.
|
The Chief Executive Officer, working with the other executive
officers of the Corporation and its affiliates, shall have the
authority and responsibility for managing the business of the
Corporation in a manner consistent with the standards of the
Corporation, and in accordance with any specific plans,
instructions or directions of the Board.
The Chief Executive Officer shall seek the advice and, in
appropriate situations, the approval of the Board with respect
to material actions to be undertaken by the Corporation,
including those that would make a significant change in the
financial structure or control of the Corporation, the
acquisition or disposition of any significant business or the
entry of the Corporation into a major new line of business.
II. Selection/Service of Board Members
|
|
|
|
A.
|
Identification. The responsibility for the
selection of new Directors resides with the Board and
shareholders. The identification, screening and recommendation
process has been delegated to the Governance Committee, which
reviews candidates for election as Directors and annually
recommends a slate of Directors for approval by the Board and
election by the shareholders. New Directors shall be the subject
of and must satisfactorily pass a background check.
|
E-1
|
|
|
|
B.
|
Non-Discrimination. Potential candidates for
membership on the Board and Committees of the Board shall not be
denied consideration by reason of race, sex, religion, color or
ethnicity. Nor shall any candidate be approached or selected
solely because of any such reason.
|
|
|
C.
|
Independence. It is intended that the Board be
comprised of a strong majority of independent Directors and no
less than are required by NASDAQ or applicable law. Independence
shall be defined as provided by the rules of NASDAQ and any
applicable law. The Board, in consultation with the
Companys Secretary, shall undertake an annual review of
the independence of all non-employee Directors. In advance of
the meeting at which this review occurs, each non-employee
Director shall provide to the Corporation for presentation to
the Board, full information regarding the Directors
business and other relationships with the Corporation and its
affiliates and with senior management and their affiliates to
enable the Board to evaluate the Directors independence.
|
|
|
|
Directors have an affirmative obligation to inform the Board of
any material changes in their circumstances or relationships
that may impact their designation by the Board as
independent. This obligation includes all business
relationships between Directors and the Corporation and its
affiliates or members of senior management and their affiliates,
whether or not such business relationships are subject to the
approval requirement set forth in the following provision.
|
|
|
D.
|
Criteria for the Nomination:
|
1. The Governance Committee shall consider for selection as
Directors those persons:
|
|
|
|
a.
|
who have the proven ability and experience to bring informed,
thoughtful and well-considered opinions to corporate management
and the Board;
|
|
|
b.
|
who have the competence, maturity and integrity to monitor and
evaluate the Corporations management, performance and
policies;
|
|
|
c.
|
who have the willingness and ability to devote the necessary
time and effort required for service on the Board;
|
|
|
|
|
d.
|
who have the capacity to provide additional strength, diversity
of view and new perceptions to the Board and its activities;
|
|
|
|
|
e.
|
who have the necessary measure of communication skills and
self-confidence to ensure ease of participation in Board
discussion; and
|
|
|
|
|
f.
|
who hold or have held a senior position with a significant
business Corporation or a position of senior leadership in an
educational, medical, religious, or other non-profit institution
or foundation of significance.
|
|
|
|
|
2.
|
Not more than one person who is or was employed, within a two
(2) year period, by the same company or organization (other
than the Corporation, directly or indirectly) may simultaneously
serve as a Director.
|
|
|
3.
|
Persons who have attained the age of 75 shall not be eligible
for election or re-election as a Director.
|
|
|
4.
|
Any Director who (i) retires from; or
(ii) discontinues their active employment with the business
or other enterprise with which they were primarily affiliated at
the time of their most recent election to the Board; or
(iii) incurs a significant reduction in responsibilities,
title or activities as related to the time of their most recent
election to the Board, shall submit their resignation upon the
occurrence of any of the aforesaid events. The Governance
Committee will review with the Board the effects of this change
upon the interests of the Company and recommend to the Board
whether to accept the resignation.
|
|
|
|
|
E.
|
Number of Board Seats. The Corporation does
not have a policy limiting the number of other company boards of
directors upon which a Director may sit. However, the Governance
Committee shall consider the number of other company boards and
other boards (or comparable governing bodies) on which a
prospective nominee is a member. It is the sense of the Board
that prospective Directors should
|
E-2
|
|
|
|
|
simultaneously serve on no more than 2 4 other
company Boards, depending on their personal circumstances.
|
Directors are expected to advise the Chairman of the Board and
the Chairman of the Governance Committee in advance of accepting
any other company directorship or any assignment to the audit
committee or compensation committee of the board of directors of
any other company.
|
|
|
|
F.
|
Size of Board. The by-laws of the Corporation
provide that the size of the Board of Directors shall consist of
not more than thirteen (13) Directors. The Board shall
determine the number of Directors as deemed appropriate by the
Board, subject to the Corporations by-laws.
|
III. Term
|
|
|
|
A.
|
Normal Terms. The Board of Directors are
classified into three classes. Each class of Directors is
elected for three year terms at the annual meeting of
shareholders on the third anniversary of their previous
election. Any vacancy in the Board for any reason, including a
vacancy resulting from an increase in the number of Directors,
may be filled by action of the Board of Directors. Directors
shall hold office from the time of their election and
qualification and shall serve until the election and
qualification of their successor or until such Directors
earlier death, resignation, disqualification or removal.
|
|
|
B.
|
Management Director Resignation. A Director
who also is an officer of the Corporation, who either resigns or
retires their officer position, shall simultaneously submit
their resignation as a Director, acceptance of which shall be at
the discretion of the other Board members.
|
|
|
C.
|
Term Limits. The Board does not believe it
should establish term limits. While term limits could help
ensure that there are fresh ideas and viewpoints available to
the Board, they hold the disadvantage of losing the contribution
of Directors who have been able to develop, over a period of
time, increasing insight into the Corporation and its operations
and, therefore, provide an increasing contribution to the Board
as a whole.
|
|
|
D.
|
Retirement. A Director who attains the age of
75 shall be required to retire from the Board at the next Annual
Shareholders meeting.
|
IV. Stock Ownership of Directors
It is the policy of the Board that all Directors hold an equity
interest in the Corporation. Toward this end, the Board expects
that all Directors own, or acquire within five years of first
becoming a Director, shares of common stock of the Corporation
(including share units held under the Corporations Board
of Directors Deferred Compensation Plan, or any successor plan)
having a market value of at least five times the annual retainer
paid to Board members. The Board recognizes that exceptions to
this policy may be necessary or appropriate in individual cases,
and may approve such exceptions from time to time as it deems
appropriate.
|
|
|
|
A.
|
Scheduling of Meetings. The Chairman, in
consultation with the other members of the Board, shall
determine the timing and length of the meetings of the Board.
The Board expects that five to six meetings at appropriate
intervals are generally desirable for the performance of the
Boards responsibilities. In addition to regularly
scheduled meetings, additional Board meetings may be called upon
appropriate notice at any time to address specific needs of the
Corporation. A special meeting of the Board may be called at any
time by the Chief Executive Officer, the Chairman, or by members
of the Board of Directors constituting no less than a majority
of the total number of independent Directors then in office.
Participation in such special meetings may be by means of
conference telephone.
|
|
|
B.
|
Agenda. The Chairman and Chief Executive
Officer shall establish the agenda for each Board meeting. Each
Director shall be entitled to suggest the inclusion of items on
the agenda, request the presence of or a report by any member of
the Corporations senior management, or at any Board
meeting raise subjects that are not on the agenda for that
meeting. Subject to reasonable exception, Directors shall be
advised of significant agenda items and shall be furnished with
appropriate supporting materials in advance of meetings of the
Board and Committees of the Board.
|
E-3
|
|
|
|
C.
|
Management Presentations. Management shall
make presentations to the Board on the performance, operations,
strategies and significant activities of the Corporation.
|
|
|
D.
|
Executive Sessions. The Board shall meet in
regularly scheduled Executive Sessions no less than twice per
year. These meetings shall take place without the participation
of the Chief Executive Officer or other members of the
Corporations management and non-independent Directors to
deal with such other matters as the Lead Director and
participating Directors may deem appropriate. Additional
Executive Sessions may be scheduled from time to time as
determined by a majority of the independent Directors in
consultation with the Lead Director. This Session, or portion
thereof, will be chaired by the Lead Director and if the Lead
Director is not present, then by the Chairman of the Committee
for the relevant subject matter discussed in the Session.
|
VI. Attendance
Board Meetings. It is expected that Board
Members will make every effort to attend Board Meetings and
meetings of their respective Committees, with the expectation
that Board Members will attend no less than collectively
seventy-five percent (75%) of such meetings, except when
exceptional circumstances prevent such attendance.
Annual Shareholders Meeting. It is expected
that Board Members will attend the Annual Shareholders Meeting,
except when exceptional circumstances prevent such attendance.
VII. Lead Director
An independent Director shall act in a lead capacity to perform
certain functions (Lead Director) as outlined below.
The Lead Director will be elected annually by the independent
Directors.
The Lead Directors responsibilities are to:
|
|
|
|
(a)
|
preside at the Executive Sessions of the independent Directors;
|
|
|
|
|
(b)
|
provide the Chairman with input into the agenda for the Board
meetings on behalf of the independent Directors and recommend
the agenda for Executive Sessions of independent Directors to
the extent deemed necessary;
|
|
|
|
|
(c)
|
act as the principal liaison between the independent Directors,
the Chairman and the CEO, and keep the Chairman advised of
activities of the independent Directors; and
|
|
|
|
|
(d)
|
follow-up
with management of the Company on open items or upon direction
from the Board.
|
VIII. Board Committees
|
|
|
|
A.
|
Generally. Standing or temporary committees,
consisting of two or more Directors, may be appointed by the
Board from time to time. The Board may vest committees with such
power and authority as the Board determines appropriate, subject
to such limitations as are set forth in the Delaware General
Corporation Law and the Corporations Certificate of
Incorporation and By-Laws. The Governance Committee shall
consider and recommend to the Board the rotation of Committee
memberships and chairmanships, as determined appropriate. The
Board does not have a practice of automatic rotation of
Committee chairs and members after a set time period. There are
many reasons to maintain an individual Director on a specific
Committee, including continuity and subject matter expertise
necessary for an effective Committee. There are currently four
standing committees:
|
Executive Committee
Audit & Information Technology Committee (Audit
Committee)
Human Resources Committee
Corporate Governance Nominating Committee (Governance
Committee)
|
|
|
|
B.
|
Charters. Each standing Committee (other than
the Executive Committee) shall have a written charter of
responsibilities, duties and authorities, which shall
periodically be reviewed by the Board. Each
|
E-4
|
|
|
|
|
Committee shall report to the full Board, as deemed necessary,
with respect to its activities, findings and recommendations.
|
|
|
|
|
C.
|
Advisors. Each Committee shall have full power
and authority to retain the services of such advisers and
experts, including counsel, as the Committee deems necessary or
appropriate with respect to specific matters within its purview.
|
|
|
D.
|
Committee Assignments. The Governance
Committee, after consideration of the desires, experience and
expertise of individual Directors, shall recommend to the Board
the assignment of Directors to Committees, including the
designation of Committee Chairs. In acting upon such
recommendation and report, the full Board shall give
consideration to the following objectives:
|
|
|
|
|
|
the target size of each Committee should be three or five
members, unless circumstances call for an exception;
|
|
|
|
Committee, Chairmanship and membership should be considered for
rotation periodically, subject to any applicable legal,
regulatory and stock exchange listing requirements; and
|
|
|
|
the Audit, Human Resources and Board Governance Committees shall
be composed entirely of independent Directors. The Executive
Committee shall include the Chief Executive Officer of the
Corporation.
|
|
|
|
|
E.
|
Committee Meetings. Each Committee Chair, in
consultation with the Chairman of the Board, Committee member
and management of the Corporation shall establish agendas and
set meetings at the frequency and length appropriate and
necessary to carry out the Committees responsibilities.
Any Director who is not a member of a particular Committee may
attend any Committee meeting with the concurrence of the
Committee Chair or a majority of the members of the Committee.
|
|
|
F.
|
Executive Committee. Recognizing that the
Executive Committee is authorized to and at times take action on
behalf of the Board, when the Executive Committee takes action
between Board meetings, the minutes or written consent
evidencing such actions shall be circulated to the full Board.
|
IX. Compensation
Outside Directors shall be appropriately compensated for their
service on the Board. This compensation shall take into
consideration the amount of time required to be devoted to Board
activities, the risks of such positions and the competitiveness
of the compensation levels. Compensation is subject to change at
the discretion of the Board. The current compensation paid to
Outside Directors shall be; an annual retainer of $40,000; a
meeting fee for Board and Committee meetings of $1,500 for
in-person meetings and $1,000 for telephone meetings. Further,
the Chairman of the Audit Committee shall be paid a fee of
$10,000 and other Board Committee Chairmen and the Lead Director
shall each be paid an additional annual fee of $5,000
(Chairmans Fee), provided that a Board member shall
be paid only one Chairmans Fee regardless of the number of
chairmanships. Board members will also receive stock option
grants under the Corporations Stock Option Plan(s). The
Company has adopted a deferred compensation plan which allows
Directors to defer payment of their Board compensation. This
plan may be changed from time to time.
X. Self-Evaluation by the Board
The Governance Committee will manage an annual self-assessment
of the Boards performance as well as follow up on
self-assessments performed by the Committees of the Board, the
results of which will be discussed with the full Board,
including reviewing and recommending to the Board changes
identified by the Committees. The Governance Committee will also
utilize the results of this self-evaluation process in assessing
and determining the characteristics and critical skills required
of prospective candidates for election to the Board and making
recommendations to the Board with respect to assignments of
Board members to various committees.
E-5
XI. Director Education
The Corporation shall assist the Board by providing appropriate
orientation programs for new Directors, which shall be designed
both to familiarize new Directors with the full scope of the
Corporations businesses and to assist new Directors in
developing and maintaining skills necessary or appropriate for
the performance of their responsibilities. The Board and the
Companys management shall similarly work together to
develop and implement appropriate continuing education programs
for the same purposes.
XII. Expenses
Directors shall be reimbursed for ordinary, necessary and
reasonable expenses incident to their service on the Board and
to their attendance at meetings of the Board, Committees of the
Board and shareholders. Requests for reimbursement for expenses
over $75.00 must be accompanied by a receipt for such expenses.
Directors shall be reimbursed for air travel expenses not
exceeding the first-class commercial air travel rate. All such
requests are to be forwarded to the Secretary of the Corporation.
XIII. Capital Expenditures
Management shall submit to the Board an Annual Capital
Expenditure Budget for Board approval at the same time the
Annual Operating Budget is submitted.
While the Capital Expenditure Budget will outline anticipated
projects, the projects may change at the discretion of
management as long as total annual capital expenditures do not
exceed the total Annual Budget and subject to the individual
expenditure approval levels established by the Board. If
management anticipates that expenditures will exceed the amount
budgeted, it must obtain Board approval for amounts that exceed
the approved budget.
Management authority to approve funding for individual
expenditures within the scope of the approved budget is as
follows:
|
|
|
Up to $5 million
|
|
Chair/Chief Executive Officer,
and
other executives with the direction of the CEO
|
Greater than $5 million
|
|
Board of Directors
|
XIV. Communication with the Board
|
|
|
|
A.
|
General Communications. All Board members,
including their Committee assignments, are identified each year
in the Companys Proxy Statement. Communications which are
intended for Board members can be sent to the Companys
Secretary at the Companys Headquarters for delivery to
individual Board members. All mail received will be opened and
screened for security purposes and mail determined to be
appropriate will be delivered to the respective Board member to
which the communication is addressed. Mail addressed to
Outside Directors or Non-Management
Directors will be forwarded or delivered to the Chairman
of the Governance Committee. Mail addressed to the Board
of Directors will be forwarded or delivered to the
Chairman of the Board.
|
|
|
B.
|
Director Nominations. The Directors welcome
and are willing to consider recommendations from shareholders
for Director nominations. Shareholders desiring to make
candidate recommendations for the Board may do so by submitting
nominations to the Company or the Companys Governance
Committee, in accordance with the Companys Bylaws and
addressed to the Corporate Secretary or to the Chairman of the
Governance Committee at the following address: DENTSPLY
International Inc., 221 West Philadelphia Street, York,
Pennsylvania
17405-0872.
|
THESE GUIDELINES/POLICIES SHALL BE SUBJECT TO CHANGE AS REQUIRED
BY LAW OR AS DEEMED APPROPRIATE BY THE BOARD OF DIRECTORS.
E-6
VOTE BY INTERNET -
www.proxyvote.com
Use the Internet to transmit your voting
instructions and for electronic delivery of information up until 11:59 P.M.
Eastern Time the day before the meeting date. Have your proxy
card in hand when you access the web site and follow the instructions to obtain
your records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE
SHAREHOLDER COMMUNICATIONS
If you would like to reduce the costs incurred
by DENTSPLY International Inc. in mailing proxy materials, you can consent to
receiving all future proxy statements, proxy cards and annual reports
electronically via e-mail or the Internet. To sign up for electronic delivery,
please follow the instructions above to vote using the Internet and, when
prompted, indicate that you agree to receive or access shareholder
communications electronically in future years.
VOTE BY PHONE -
1-800-690-6903
Use any touch-tone telephone to transmit your voting
instructions up until 11:59 P.M. Eastern Time the day before the meeting date. Have your proxy card in hand when you call and then follow
the instructions.
VOTE BY MAIL
Mark, sign and date
your proxy card and return it in the postage-paid envelope we have provided or
return it to DENTSPLY International Inc., c/o ADP, 51 Mercedes Way, Edgewood, NY
11717.
|
|
|
|
|
NAME |
|
|
|
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
DENTSPLY INTERNATIONAL INC - COMMON |
|
|
123,456,789,012.12345 |
|
PAGE
2 OF
2
|
|
|
|
|
TO VOTE, MARK BLOCKS BELOW
IN BLUE OR BLACK INK AS FOLLOWS: x |
|
DNTSY1 |
|
KEEP THIS PORTION FOR YOUR RECORDS |
|
|
|
|
|
DETACH AND RETURN THIS PORTION ONLY |
THIS PROXY CARD IS VALID ONLY WHEN
SIGNED AND DATED.
DENTSPLY INTERNATIONAL INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Board of Directors recommends a vote
FOR all proposals. |
02 |
0000000000 |
|
215063182004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prop 1 |
|
Directors |
|
|
|
For |
|
Withhold |
|
For All |
|
To withhold authority to vote for any nominee(s), mark For All Except and write
the number(s) of the
individual nominee(s) on the line below. |
|
|
01) PAULA H. CHOLMONDELEY |
|
|
|
All |
|
All |
|
Except |
|
|
|
02) MICHAEL J. COLEMAN |
|
|
|
|
|
|
|
|
|
|
|
03) JOHN C. MILES II |
|
|
|
o |
|
o |
|
o |
|
|
|
|
04) W. KEITH SMITH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For |
|
Against |
|
Abstain |
|
|
|
|
|
|
|
|
|
Prop 2 |
|
PROPOSAL TO RATIFY THE APPOINTMENT OF
PRICEWATERHOUSECOOPERS LLP, INDEPENDENT ACCOUNTANTS, TO AUDIT THE BOOKS
AND ACCOUNTS OF THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2007. |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
Prop 3 |
|
PROPOSAL TO APPROVE AMENDMENTS TO THE 2002 EQUITY INCENTIVE PLAN. |
|
o |
|
o |
|
o |
|
|
|
|
|
|
|
|
|
*NOTE* SUCH OTHER BUSINESS
AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF.
|
|
|
|
|
For comments, please check this box and
write them on the
back where indicated.
o
|
|
|
|
|
AUTO DATA PROCESSING
INVESTOR COMM SERVICES
ATTENTION:
TEST PRINT
51 MERCEDES WAY
EDGEWOOD, NY
11717
|
|
|
Yes |
|
No |
Please indicate if you
plan to attend this meeting.
|
|
o
|
|
o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
123,456,789,012 |
|
|
|
|
|
|
|
P45116 |
|
|
|
|
|
|
|
249030107 |
Signature [PLEASE SIGN WITHIN BOX] |
|
|
Date |
|
|
|
|
Signature (Joint Owners) |
|
|
Date |
|
64 |
DO NOT RETURN
PROXY CARD IF YOU ARE VOTING BY INTERNET OR TELEPHONE
Solicited on behalf
of the Board of Directors of
DENTSPLY International Inc.
The undersigned
stockholder of DENTSPLY International Inc. (the Company) hereby appoints Brian
M. Addison as the attorney and proxy of the undersigned, with full power of
substitution, to vote all shares of Common Stock, par value $.01 per share, of
the Company which the undersigned would be entitled to vote if personally
present at the Annual Meeting of Stockholders of the Company, to be held at the
Companys Employee Meeting Room at DENTSPLY International Inc., 570 West College
Avenue, York, Pennsylvania, on Tuesday, May 5, 2007, commencing at 9:30
a.m., local time, and at any adjournment or postponement thereof, as indicated
on the reverse side.
This proxy also
provides voting instructions for shares held by T. Rowe Price Retirement Plan
Services, Inc., the trustee for the DENTSPLY International Inc. Employee Stock
Ownership Plan (the ESOP) and/or DENTSPLY International Inc. 401(k) Savings
Plan (the 401 (k)), I hereby instruct you to (a) vote the shares of
Common Stock, par value $.01 per share (Common Stock) of DENTSPLY
International Inc. (the Company) allocated to the ESOP and/or 401(k) account
in accordance with the directions on the reverse side and (b) to grant a
proxy to the proxy nominated by the Companys Board of Directors authorizing him
to vote in his discretion upon such other matters as may properly come before
the meeting.
This proxy/voting
instruction card is solicited pursuant to a separate Notice of Annual Meeting
and Proxy Statement, receipt of which is hereby acknowledged. This card should
be voted, by mail, Internet or telephone, in time to reach the
Companys proxy
tabulator, Automatic Data Processing, by 11:59 p.m. Eastern Time on
Monday, May 11, 2007, for all registered shares to be voted and by 5:00
p.m. Eastern Time on Friday, May 11, 2007, for the Trustee to vote the Plan
shares.
(If you noted any Comments above,
please mark corresponding box on the reverse side.)
(Continued and to be
signed on reverse side)